<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Genetics on VitaminDWiki</title><link>/categories/genetics.html</link><description>Recent content in Genetics on VitaminDWiki</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Tue, 28 Feb 2017 00:00:00 +0000</lastBuildDate><atom:link href="/categories/genetics/index.xml" rel="self" type="application/rss+xml"/><item><title>Vitamin D during pregnancy – dramatic changes in both metabolism and genes</title><link>/posts/vitamin-d-during-pregnancy-dramatic-changes-in-both-metabolism-and-genes.html</link><pubDate>Tue, 28 Feb 2017 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-during-pregnancy-dramatic-changes-in-both-metabolism-and-genes.html</guid><description/></item><item><title>Vitamin D restricted in getting to cells by genes, obesity, etc</title><link>/posts/vitamin-d-restricted-in-getting-to-cells-by-genes-obesity-etc.html</link><pubDate>Wed, 01 Feb 2017 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-restricted-in-getting-to-cells-by-genes-obesity-etc.html</guid><description/></item><item><title>Vitamin D effects on lung immunity and respiratory diseases – 2011</title><link>/posts/vitamin-d-effects-on-lung-immunity-and-respiratory-diseases-2011.html</link><pubDate>Sun, 29 Jan 2017 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-effects-on-lung-immunity-and-respiratory-diseases-2011.html</guid><description/></item><item><title>Rare mutation of CYP24A1 gene results in Vitamin D accumulating</title><link>/posts/rare-mutation-of-cyp24a1-gene-results-in-vitamin-d-accumulating.html</link><pubDate>Mon, 23 Jan 2017 00:00:00 +0000</pubDate><guid>/posts/rare-mutation-of-cyp24a1-gene-results-in-vitamin-d-accumulating.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#calcium-pyrophosphate-deposition-disease-revealing-a-hypersensitivity-to-vitamin-d---2017">Calcium pyrophosphate deposition disease revealing a hypersensitivity to vitamin D - 2017&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#overlapping-phenotypes-associated-with-cyp24a1-slc34a1-and-slc34a3-mutations-a-cohort-study-of-patients-with-hypersensitivity-to-vitamin-d---oct-2021">Overlapping Phenotypes Associated With CYP24A1, SLC34A1, and SLC34A3 Mutations: A Cohort Study of Patients With Hypersensitivity to Vitamin D - Oct 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-a-hrefpostsvitamin-d-non-responders-may-have-one-or-more-poor-genes-gc-lipc-cyp24a1-and-pde3b-stylecolor-red-text-decoration-underline-titlethis-postcategory-does-not-exist-yet-vitamin-d-non-responders-may-have-one-or-more-poor-genes-gc-lipc-cyp24a1-and-pde3b--oct-2022vitamin-d-non-responders-may-have-one-or-more-poor-genes-gc-lipc-cyp24a1-and-pde3b--oct-2022a">See also &lt;a href="/posts/vitamin-d-non-responders-may-have-one-or-more-poor-genes-gc-lipc-cyp24a1-and-pde3b" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Vitamin D non-responders may have one or more poor genes: GC, LIPC, CYP24A1, and PDE3B – Oct 2022">Vitamin D non-responders may have one or more poor genes: GC, LIPC, CYP24A1, and PDE3B – Oct 2022&lt;/a>&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="calcium-pyrophosphate-deposition-disease-revealing-a-hypersensitivity-to-vitamin-d---2017">Calcium pyrophosphate deposition disease revealing a hypersensitivity to vitamin D - 2017&lt;/h4>
&lt;p>Joint Bone Spine. 2017 Jan 18. pii: S1297-319X(16)30209-3. &lt;a href="https://doi.org/10.1016/j.jbspin.2016.11.006">doi: 10.1016/j.jbspin.2016.11.006&lt;/a>&lt;/p></description></item><item><title>Mendelian proof that low vitamin D (due to 3 genes) increase risk of MS by 20 percent</title><link>/posts/mendelian-proof-that-low-vitamin-d-due-to-3-genes-increase-risk-of-ms-by-20-percent.html</link><pubDate>Sun, 15 Jan 2017 00:00:00 +0000</pubDate><guid>/posts/mendelian-proof-that-low-vitamin-d-due-to-3-genes-increase-risk-of-ms-by-20-percent.html</guid><description/></item><item><title>5839 genes changed during pregnancy (many genes were related to Vitamin D)</title><link>/posts/5839-genes-changed-during-pregnancy-many-genes-were-related-to-vitamin-d.html</link><pubDate>Wed, 11 Jan 2017 00:00:00 +0000</pubDate><guid>/posts/5839-genes-changed-during-pregnancy-many-genes-were-related-to-vitamin-d.html</guid><description/></item><item><title>Autoimmune risk gene ZMIZ1 is associated with both MS and Vitamin D</title><link>/posts/autoimmune-risk-gene-zmiz1-is-associated-with-both-ms-and-vitamin-d.html</link><pubDate>Thu, 05 Jan 2017 00:00:00 +0000</pubDate><guid>/posts/autoimmune-risk-gene-zmiz1-is-associated-with-both-ms-and-vitamin-d.html</guid><description/></item><item><title>Multiple Sclerosis relapse in children is twice as likely having a Vitamin D Gene score of 6</title><link>/posts/multiple-sclerosis-relapse-in-children-is-twice-as-likely-having-a-vitamin-d-gene-score-of-6.html</link><pubDate>Thu, 22 Dec 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-relapse-in-children-is-twice-as-likely-having-a-vitamin-d-gene-score-of-6.html</guid><description/></item><item><title>Vitamin D - Binding Protein, Receptor, enzymes and health benefits - review</title><link>/posts/vitamin-d-binding-protein-receptor-enzymes-and-health-benefits-review.html</link><pubDate>Tue, 20 Dec 2016 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-binding-protein-receptor-enzymes-and-health-benefits-review.html</guid><description/></item><item><title>Genes which reduce blood-level vitamin D increase the risk of Alzheimer’s disease</title><link>/posts/genes-which-reduce-blood-level-vitamin-d-increase-the-risk-of-alzheimers-disease.html</link><pubDate>Fri, 16 Dec 2016 00:00:00 +0000</pubDate><guid>/posts/genes-which-reduce-blood-level-vitamin-d-increase-the-risk-of-alzheimers-disease.html</guid><description/></item><item><title>Preeclampsia 3.5 times more likely if low vitamin D (affects 348 Vit. D genes) – RCT</title><link>/posts/preeclampsia-35-times-more-likely-if-low-vitamin-d-affects-348-vit-d-genes-rct.html</link><pubDate>Tue, 15 Nov 2016 00:00:00 +0000</pubDate><guid>/posts/preeclampsia-35-times-more-likely-if-low-vitamin-d-affects-348-vit-d-genes-rct.html</guid><description/></item><item><title>Less vitamin D generated from sunlight by schizophrenia patients – 2016</title><link>/posts/less-vitamin-d-generated-from-sunlight-by-schizophrenia-patients-2016.html</link><pubDate>Fri, 14 Oct 2016 00:00:00 +0000</pubDate><guid>/posts/less-vitamin-d-generated-from-sunlight-by-schizophrenia-patients-2016.html</guid><description/></item><item><title>DHCR7 enzyme (gene) synthesizes cholesterol or vitamin D (when UVB is available)</title><link>/posts/dhcr7-enzyme-gene-synthesizes-cholesterol-or-vitamin-d-when-uvb-is-available.html</link><pubDate>Tue, 04 Oct 2016 00:00:00 +0000</pubDate><guid>/posts/dhcr7-enzyme-gene-synthesizes-cholesterol-or-vitamin-d-when-uvb-is-available.html</guid><description/></item><item><title>CYP2R1 mutations also cause vitamin D-deficient rickets</title><link>/posts/cyp2r1-mutations-also-cause-vitamin-d-deficient-rickets.html</link><pubDate>Tue, 02 Aug 2016 00:00:00 +0000</pubDate><guid>/posts/cyp2r1-mutations-also-cause-vitamin-d-deficient-rickets.html</guid><description/></item><item><title>Multiple Sclerosis and obesity share some gene problems (as well as low vitamin D)</title><link>/posts/multiple-sclerosis-and-obesity-share-some-gene-problems-as-well-as-low-vitamin-d.html</link><pubDate>Thu, 30 Jun 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-and-obesity-share-some-gene-problems-as-well-as-low-vitamin-d.html</guid><description/></item><item><title>Diabetes changes liver genes so as to destroy (catabolize) Vitamin D</title><link>/posts/diabetes-changes-liver-genes-so-as-to-destroy-catabolize-vitamin-d.html</link><pubDate>Tue, 10 May 2016 00:00:00 +0000</pubDate><guid>/posts/diabetes-changes-liver-genes-so-as-to-destroy-catabolize-vitamin-d.html</guid><description>&lt;p>&lt;strong>Chart from the web shows that CYP24A1 (which destroys Vitamin D)&lt;br>
is normally activated by diabetes (2),&lt;br>
but is deactivated by addition of Vitamin D (3) in rats&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/cyp24a1-unexpressed-by-addtion-of-vitamin-d.jpg" alt="image" width="500">
&lt;/div>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/cyp24-liver-sci-hub.pdf">Download the PDF from Sci-Hub via VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;p>Association of liver calcitriol (active vitamin D metabolite) catabolism with osteomalacia during prolonged use of certain drugs was reported in several recent studies. To examine whether the increased calcitriol catabolism could be a potential link between ageing/diabetes mellitus (DM) and bone loss, we studied the dynamic of expression of CYP24, the main calcitriol catabolising enzyme in the liver of rats during ageing and a long-term experimental DM1. DM1 model was induced with intraperitoneally injected streptozotocin (STZ) (55 mg/kg). Sprague-Dawley rats were sacrificed 6 and 12 months after the DM1 induction. The immunohistochemical analyses of CYP24 and transforming growth factor ß 1 (TGF-ß1) expression in the liver were performed. We found that ageing and long-term DM1 resulted in a significantly increased expression of CYP24 in hepatocytes, as well as in non-hepatocyte liver cells (Kupffer cells, hepatic stellate cells and sinusoidal endothelial cells). Ageing and long-term DM1 resulted in an increased expression of TGF-ß1 as well. Expression of CYP24 coexisted with the expression of TGF-ß1 in all types of hepatic cells.&lt;/p></description></item><item><title>Low vitamin D in pregnancy – epigenetic pancreas problems in offspring (mice)</title><link>/posts/low-vitamin-d-in-pregnancy-epigenetic-pancreas-problems-in-offspring-mice.html</link><pubDate>Thu, 05 May 2016 00:00:00 +0000</pubDate><guid>/posts/low-vitamin-d-in-pregnancy-epigenetic-pancreas-problems-in-offspring-mice.html</guid><description>&lt;h4 id="maternal-vitamin-d-restricted-diet-has-consequences-in-the-formation-of-pancreatic-isletinsulin-signaling-in-the-adult-offspring-of-mice">Maternal vitamin D-restricted diet has consequences in the formation of pancreatic islet/insulin-signaling in the adult offspring of mice.&lt;/h4>
&lt;p>Endocrine. 2016 May 3. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Maia-Ceciliano TC1, Barreto-Vianna AR1, Barbosa-da-Silva S1, Aguila MB1, Faria TS1, Mandarim-de-Lacerda CA2.&lt;/p>
&lt;p>1Laboratorio de Morfometria, Metabolismo e Doenca Cardiovascular, Centro Biomedico, Instituto de Biologia, Universidade do Estado de Rio de Janeiro - UERJ, Av. 28 de Setembro, 87 fds, Rio de Janeiro, RJ, 20551-030, Brazil.&lt;/p></description></item><item><title>Health problems that run in families are often associated with low vitamin D</title><link>/posts/health-problems-that-run-in-families-are-often-associated-with-low-vitamin-d.html</link><pubDate>Fri, 25 Mar 2016 00:00:00 +0000</pubDate><guid>/posts/health-problems-that-run-in-families-are-often-associated-with-low-vitamin-d.html</guid><description>&lt;h4 id="see-also-heritability-on-vitamindwiki">See also heritability on VitaminDWiki&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/majority-of-heritable-diseases-are-associated-with-vitamin-d-from-4-million-health-records">Majority of heritable diseases are associated with vitamin D (from 4 million health records) – July 2016&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-insufficiency-in-child-15x-more-likely-if-father-is-vitamin-d-insufficient" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Vitamin D insufficiency in child 15X more likely if father is Vitamin D insufficient – June 2021">Vitamin D insufficiency in child 15X more likely if father is Vitamin D insufficient – June 2021&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-heritability-twin-studies-20-percent-to-85-percent-gwas-5-percent" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Vitamin D Heritability: twin studies – 20 percent to 85 percent, GWAS 5 percent – Oct 2018">Vitamin D Heritability: twin studies – 20 percent to 85 percent, GWAS 5 percent – Oct 2018&lt;/a>&lt;/p></description></item><item><title>Vitamin D dose size needed – VitD testing tells only a portion of the story</title><link>/posts/vitamin-d-dose-size-needed-vitd-testing-tells-only-a-portion-of-the-story.html</link><pubDate>Wed, 20 Jan 2016 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-dose-size-needed-vitd-testing-tells-only-a-portion-of-the-story.html</guid><description/></item><item><title>Osteoporosis is associated with more than vitamin D genes</title><link>/posts/osteoporosis-is-associated-with-more-than-vitamin-d-genes.html</link><pubDate>Sun, 03 Jan 2016 00:00:00 +0000</pubDate><guid>/posts/osteoporosis-is-associated-with-more-than-vitamin-d-genes.html</guid><description/></item><item><title>Genes associated with low vitamin D also associated with childhood tooth decay</title><link>/posts/genes-associated-with-low-vitamin-d-also-associated-with-childhood-tooth-decay.html</link><pubDate>Mon, 21 Dec 2015 00:00:00 +0000</pubDate><guid>/posts/genes-associated-with-low-vitamin-d-also-associated-with-childhood-tooth-decay.html</guid><description>&lt;h4 id="re-examining-the-association-between-vitamin-d-and-childhood-caries">Re-Examining the Association between Vitamin D and Childhood Caries&lt;/h4>
&lt;p>PLOS ONE December 21, 2015DOI: 10.1371/journal.pone.0143769&lt;/p>
&lt;p>Tom Dudding, Steve J. Thomas, Karen Duncan, Debbie A. Lawlor, Nicholas J. Timpson&lt;/p>
&lt;p>Background: Previous studies have reported an inverse association between vitamin D and childhood dental caries, but whether this is causal is unclear.&lt;/p>
&lt;p>Objective:To determine the causal effect of circulating 25-hydroxyvitamin D concentration on dental caries experience, early caries onset and the requirement for a dental general anesthetic.&lt;/p></description></item><item><title>Genes and Vitamin D – literature review</title><link>/posts/genes-and-vitamin-d-literature-review.html</link><pubDate>Thu, 17 Dec 2015 00:00:00 +0000</pubDate><guid>/posts/genes-and-vitamin-d-literature-review.html</guid><description>&lt;h4 id="single-nucleotide-polymorphisms-in-the-vitamin-d-pathway-associating-with-circulating-concentrations-of-vitamin-d-metabolites-and-non-skeletal-health-outcomes-review-of-genetic-association-studies">Single nucleotide polymorphisms in the vitamin D pathway associating with circulating concentrations of vitamin D metabolites and non-skeletal health outcomes: review of genetic association studies.&lt;/h4>
&lt;p>The Journal of Steroid Biochemistry and Molecular Biology, doi:10.1016/j.jsbmb.2015.12.007&lt;/p>
&lt;p>David A Jolliffe, , Robert T Walton, Christopher J Griffiths, Adrian R Martineau &lt;a href="mailto:a.martineau@qmul.ac.uk">a.martineau@qmul.ac.uk&lt;/a>&lt;/p>
&lt;p>&lt;strong>Highlights&lt;/strong>&lt;/p>
&lt;p>• We review a total of 120 genetic association studies on vitamin D pathway SNP&lt;/p>
&lt;p>• Significant associations reported for a total of 55 SNP in 11 vit D pathway genes&lt;/p></description></item><item><title>Molecular Approaches for Optimizing Vitamin D (one size does not fit all) – Carlberg</title><link>/posts/molecular-approaches-for-optimizing-vitamin-d-one-size-does-not-fit-all-carlberg.html</link><pubDate>Tue, 08 Dec 2015 00:00:00 +0000</pubDate><guid>/posts/molecular-approaches-for-optimizing-vitamin-d-one-size-does-not-fit-all-carlberg.html</guid><description>&lt;h4 id="molecular-approaches-for-optimizing-vitamin-d-supplementation">Molecular Approaches for Optimizing Vitamin D Supplementation&lt;/h4>
&lt;p>Vitamins &amp;amp; Hormones, online 30 November 2015&lt;/p>
&lt;p>&lt;strong>Carsten Carlberg&lt;/strong> &lt;a href="mailto:carsten.carlberg@uef.fi">carsten.carlberg@uef.fi&lt;/a>&lt;/p>
&lt;p>&lt;strong>VitaminDWiki quick-read comment on the study&lt;/strong>&lt;/p>
&lt;p>Genes are responsible for much of the individual variation in response to vitamin D.&lt;/p>
&lt;p>Author introduces a concept of a &lt;strong>vitamin D Index&lt;/strong> which could be made based on before/after measurements of vitamin D levels along with before/after DNA analysis of 4 – 20 genes (to measure affect of Vitamin D intervention).&lt;/p></description></item><item><title>CYP2R1 and GC variations decrease vitamin D response – PHD thesis</title><link>/posts/cyp2r1-and-gc-variations-decrease-vitamin-d-response-phd-thesis.html</link><pubDate>Mon, 23 Nov 2015 00:00:00 +0000</pubDate><guid>/posts/cyp2r1-and-gc-variations-decrease-vitamin-d-response-phd-thesis.html</guid><description>&lt;h4 id="common-genetic-variations-in-the-cyp2r1-and-gc-genes-are-determinants-of-vitamin-d-status-in-danes">Common genetic variations in the CYP2R1 and GC genes are determinants of vitamin D status in Danes&lt;/h4>
&lt;p>Nissen, Ioanna&lt;/p>
&lt;p>Technical University of Denmark, National Food Institute, Division of Nutrition&lt;/p>
&lt;p>Vitamin D is considered a key fat-soluble vitamin critically important for good bone- and overall health throughout life. Vitamin D deficiency increases the risk of developing rickets, osteomalacia and osteoporosis, and moreover increases the risk of various non-skeletal adverse health outcomes including cardiovascular diseases, autoimmune diseases, some cancers and overall mortality. In humans, vitamin D is mainly synthesized in the skin after solar exposure and only a small amount is obtained through the diet. An inter-individual variation in vitamin D status exists, which may be explained by genetic variation in vitamin D modulating genes. Twin and family-based studies indicate that genetic variation may have an appreciable influence on vitamin D status. Moreover, several candidate gene studies including two genome-wide association studies (GWAS) have found single nucleotide polymorphisms (SNPs) in CYP2R1, CYP24A1, CYP27B1, C10orf88, DHCR7/NADSYN1, GC and VDR genes to be associated with vitamin D status. The main hypothesis of this work was that genetically determined variation in vitamin D metabolism would influence the effect of vitamin D sources (vitamin D-supplementation and ultraviolet (UV)-B) on vitamin D status. This was done by assessing the association between 25 SNPs located in the CYP2R1, CYP24A1, CYP27B1, C10orf88, DHCR7/NADSYN1, GC and VDR genes and vitamin D status in &lt;strong>756 participants&lt;/strong> in the VitmaD study in late summer (paper I), at the end of a winter season (paper II), after 6 months intake of vitamin D3-fortified bread and milk (paper II) and in 92 participants in the VitDgen study after artificial UVB irradiation during winter (paper III). Common genetic variations in the CYP2R1 and GC genes were found to be important determinants of vitamin D status in three out of four scenarios:&lt;/p></description></item><item><title>Colon cancer 30 percent more likely if problems with Vitamin D genes CYP24A1 or CYP27B1</title><link>/posts/colon-cancer-30-percent-more-likely-if-problems-with-vitamin-d-genes-cyp24a1-or-cyp27b1.html</link><pubDate>Mon, 16 Nov 2015 00:00:00 +0000</pubDate><guid>/posts/colon-cancer-30-percent-more-likely-if-problems-with-vitamin-d-genes-cyp24a1-or-cyp27b1.html</guid><description/></item><item><title>Benefits of Vitamin D often limited by genes</title><link>/posts/benefits-of-vitamin-d-often-limited-by-genes.html</link><pubDate>Wed, 09 Sep 2015 00:00:00 +0000</pubDate><guid>/posts/benefits-of-vitamin-d-often-limited-by-genes.html</guid><description>&lt;!-- ~tc~ start ~/tc~ -->
&lt;p>Vitamin D (Cholecalciferol in blood, fat, breast milk)&lt;/p>
&lt;p>Processing by Liver into &amp;lsquo;Calcidiol is limited by&lt;/p>
&lt;p>               &lt;span style="color:#00F;">CYP24A1 gene&lt;/span>&lt;/p>
&lt;p>Outside of the liver Calcidiol&amp;rsquo; production is limited by&lt;/p>
&lt;p>           &lt;span style="color:#00F;">CYP2R1 gene&lt;/span>&lt;/p>
&lt;p>&lt;strong>&lt;span style="color:#F00;">Measured Vit D&lt;/span>&lt;/strong> = Calcidiol&lt;/p>
&lt;p>                &lt;strong>the following genes are invisible to vit D test&lt;/strong>&lt;/p>
&lt;p>Only a portion of Calcidiol is bio-available&lt;/p>
&lt;p>           the rest is tied up by &lt;strong>Vit D Binding Protein&lt;/strong> = GC&lt;/p>
&lt;p>Kidney excreting = Calcidiol&lt;/p>
&lt;p>           is a function of &lt;strong>CYP24A1 gene&lt;/strong>&lt;/p></description></item><item><title>2 Genes make AMD 6X more likely if low vitamin D</title><link>/posts/2-genes-make-amd-6x-more-likely-if-low-vitamin-d.html</link><pubDate>Fri, 28 Aug 2015 00:00:00 +0000</pubDate><guid>/posts/2-genes-make-amd-6x-more-likely-if-low-vitamin-d.html</guid><description>&lt;h4 id="association-between-vitamin-d-status-and-age-related-macular-degeneration-by-genetic-risk">Association Between Vitamin D Status and Age-Related Macular Degeneration by Genetic Risk.&lt;/h4>
&lt;p>JAMA Ophthalmol. 2015 Aug 27. &lt;a href="https://doi.org/10.1001/jamaophthalmol.2015.2715.">doi: 10.1001/jamaophthalmol.2015.2715.&lt;/a> &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Millen AE1, Meyers KJ2, Liu Z2, Engelman CD3, Wallace RB4, LeBlanc ES5, Tinker LF6, Iyengar SK7, Robinson JG8, Sarto GE9, Mares JA2.&lt;/p>
&lt;p>1Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, The State University of New York, Buffalo.&lt;/p>
&lt;p>2Department of Ophthalmology and Visual Sciences, The University of Wisconsin, Madison.&lt;/p></description></item><item><title>Genes make Multiple Sclerosis 2X more likely unless get more vitamin D</title><link>/posts/genes-make-multiple-sclerosis-2x-more-likely-unless-get-more-vitamin-d.html</link><pubDate>Wed, 26 Aug 2015 00:00:00 +0000</pubDate><guid>/posts/genes-make-multiple-sclerosis-2x-more-likely-unless-get-more-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-and-risk-of-multiple-sclerosis-a-mendelian-randomization-study---2015">Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study - 2015&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#plos-editors-summary">(PLOS) Editors&amp;rsquo; Summary&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#methods">Methods&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#association-of-sunlight-snps-with-multiple-sclerosis-susceptibility">Association of SUNLIGHT SNPs with Multiple Sclerosis Susceptibility&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#results">Results&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#mendelian-randomization-analysis-for-the-association-of-25ohd-with-multiple-sclerosis-risk">Mendelian Randomization Analysis for the Association of 25OHD with Multiple Sclerosis Risk&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#discussion">Discussion&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#59-references">59 References&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#expert-reaction-to-new-study-on-vitamin-d-deficiency-and-ms">Expert reaction to new study on vitamin D deficiency and MS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#extensive-positive-comments-on-study-in-neurology-today---sept-2015">Extensive positive comments on study in Neurology Today - Sept 2015&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h3 id="vitamin-d-and-risk-of-multiple-sclerosis-a-mendelian-randomization-study---2015">Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study - 2015&lt;/h3>
&lt;p>PLOS ONE&lt;/p></description></item><item><title>Neurofibromatosis – 1 in 3500 have it, associated with low vitamin D</title><link>/posts/neurofibromatosis-1-in-3500-have-it-associated-with-low-vitamin-d.html</link><pubDate>Sat, 08 Aug 2015 00:00:00 +0000</pubDate><guid>/posts/neurofibromatosis-1-in-3500-have-it-associated-with-low-vitamin-d.html</guid><description>&lt;p>NF is similar to Multiple Sclerosis:&lt;/p>
&lt;ol>
&lt;li>
&lt;p>Both have brain lesions&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Both are treated by Vitamin D&lt;/p>
&lt;/li>
&lt;/ol>
&lt;blockquote>
&lt;p>See NF - Vitamin D Clinical Trial listed below - results due ~2021&lt;/p>
&lt;/blockquote>
&lt;ol>
&lt;li>
&lt;p>Both are treated by UVB&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Both have more problems if poor Vitamin D Receptor&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Both have similar cormorbidities (autism, ADHD, etc)&lt;/p>
&lt;/li>
&lt;/ol>
&lt;p>Note: Multiple Sclerosis rate is 3X that of NF about 1 in 1,000&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#overview-nf">Overview NF&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-lower-in-children-with-nf--perhaps-because-indoors">Vitamin D lower in children with NF – perhaps because indoors&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-level-similar-in-siblings">Vitamin D level similar in siblings&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#nf-idential-twins---2019">NF Idential Twins - 2019&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#nf-14-ng-controls-31-ng-number-of-dermal-neurofibromas-inversely-proportional-to-vitamin-d">NF: 14 ng, controls 31 ng, number of dermal neurofibromas inversely proportional to Vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#nf-clinical-trial-using-4000-iu-of-vitamin-d">NF Clinical trial using 4,000 IU of Vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#one-of-the-natural-cures-for-nf-is-vitamin-d">One of the natural cures for NF is Vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#nf-has-more-seasonal-variation-in-vitamin-d-levels-than-controls--wonder-why">NF has MORE seasonal variation in vitamin D levels than controls – wonder why&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#more-dermal-neurofibromas-if-poor-vitamin-d-receptor---oct-2018">More dermal neurofibromas if poor Vitamin D Receptor - Oct 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-vdr-did-not-vary-between-nf1-and-controls---2015">Vitamin D and VDR did not vary between NF1 and controls - 2015&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#nih-overview-of-nf">NIH overview of NF&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#nf-skin-pictures-and-skin-is-only-a-small-part-of-nf-problems">NF skin pictures (and skin is only a small part of NF problems)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#wikipedia-on-rare-diseases">Wikipedia on Rare Diseases&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#neurofibromatosis-chronological-history-and-current-issues---may-2013">Neurofibromatosis: chronological history and current issues - May 2013&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#intellectual-problems-adhd-autism-spectrum-disorder-and-migraine-are-major-neurological-comorbidities-in-nf1---jan-2018">Intellectual problems, ADHD, autism spectrum disorder, and migraine are major neurological comorbidities in NF1 - Jan 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d3--and-uv-treat-neurofibromatosis---1---2017-book-chapter">Vitamin D3 and UV treat Neurofibromatosis - 1 - 2017 book Chapter&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/nf-5minutes.jpg" alt="image" width="600">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/nf-chart.jpg" alt="image" width="600">
&lt;h3 id="overview-nf">Overview NF&lt;/h3>
&lt;p>Neurofibromatosis has a 50 percent chance of developing in a child who has one parent with the mutated gene.&lt;/p></description></item><item><title>Immune modulation by Vitamin D, food allergy, chart of genes</title><link>/posts/immune-modulation-by-vitamin-d-food-allergy-chart-of-genes.html</link><pubDate>Sat, 01 Aug 2015 00:00:00 +0000</pubDate><guid>/posts/immune-modulation-by-vitamin-d-food-allergy-chart-of-genes.html</guid><description>&lt;h4 id="immune-modulation-by-vitamin-d-and-its-relevance-to-food-allergy">Immune Modulation by Vitamin D and Its Relevance to Food Allergy&lt;/h4>
&lt;p>Nutrients 2015, 7(8), 6088-6108; doi:10.3390/nu7085271&lt;/p>
&lt;p>Noor H. A. Suaini 1,2, Yuxia Zhang 3,4, Peter J. Vuillermin 1,5,6, Katrina J. Allen 1,2,7,8, &lt;a href="mailto:katie.allen@mcri.edu.au">katie.allen@mcri.edu.au&lt;/a> and Leonard C. Harrison 3,4&lt;/p>
&lt;p>1 Murdoch Childrens Research Institute, The Royal Children&amp;rsquo;s Hospital, Parkville, VIC 3052, Australia&lt;/p>
&lt;p>2 Department of Paediatrics, University of Melbourne, Parkville VIC 3052, Australia&lt;/p>
&lt;p>3 The Walter and Eliza Hall Institute of Medical Research, Parkville VIC 3052, Australia&lt;/p></description></item><item><title>Micronutrients, methylation, epigenetics, longevity podcast by Rhonda Patrick and Tim Ferriss</title><link>/posts/micronutrients-methylation-epigenetics-longevity-podcast-by-rhonda-patrick-and-tim-ferriss.html</link><pubDate>Mon, 22 Jun 2015 00:00:00 +0000</pubDate><guid>/posts/micronutrients-methylation-epigenetics-longevity-podcast-by-rhonda-patrick-and-tim-ferriss.html</guid><description/></item><item><title>Vitamin D insufficiency was 3.7 X more likely if CYP2R1 gene variation</title><link>/posts/vitamin-d-insufficiency-was-37-x-more-likely-if-cyp2r1-gene-variation.html</link><pubDate>Tue, 02 Jun 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-insufficiency-was-37-x-more-likely-if-cyp2r1-gene-variation.html</guid><description/></item><item><title>Genes in the blood are not static, 20 percent change with the seasons - such as Vitamin D Receptor</title><link>/posts/genes-in-the-blood-are-not-static-20-percent-change-with-the-seasons-such-as-vitamin-d-receptor.html</link><pubDate>Tue, 12 May 2015 00:00:00 +0000</pubDate><guid>/posts/genes-in-the-blood-are-not-static-20-percent-change-with-the-seasons-such-as-vitamin-d-receptor.html</guid><description/></item><item><title>Gene activation by high dose vitamin D - both quick and long term</title><link>/posts/gene-activation-by-high-dose-vitamin-d-both-quick-and-long-term.html</link><pubDate>Sun, 19 Apr 2015 00:00:00 +0000</pubDate><guid>/posts/gene-activation-by-high-dose-vitamin-d-both-quick-and-long-term.html</guid><description/></item><item><title>Skin damaged by sun helped by vitamin D supplementation - pilot study</title><link>/posts/skin-damaged-by-sun-helped-by-vitamin-d-supplementation-pilot-study.html</link><pubDate>Fri, 03 Apr 2015 00:00:00 +0000</pubDate><guid>/posts/skin-damaged-by-sun-helped-by-vitamin-d-supplementation-pilot-study.html</guid><description>&lt;h4 id="pilot-study-on-the-bioactivity-of-vitamin-d-in-the-skin-after-oral-supplementation">Pilot Study on the Bioactivity of Vitamin D in the Skin after Oral Supplementation&lt;/h4>
&lt;p>Cancer Prevention Research 14-0280 Published OnlineFirst April 2, 2015; &lt;a href="https://doi.org/10.1158/1940-6207.">doi: 10.1158/1940-6207.&lt;/a>&lt;/p>
&lt;p>Clara Curiel-Lewandrowski1,*, Jean Y. Tang2, Janine G. Einspahr3, Yira Bermudez4, Chiu-Hsieh Hsu5, Melika Rezaee6, Alex Hao Lee6, Joseph Tangrea7, Howard L. Parnes8, David S. Alberts9, and H-H S Chow4&lt;/p>
&lt;p>1Dermatology, The University of Arizona Cancer Center&lt;/p>
&lt;p>2Dermatology, Stanford School of Medicine, Stanford University&lt;/p>
&lt;p>3Medicine, The University of Arizona Cancer Center&lt;/p></description></item><item><title>Telomeres (which extend life) appear to be extended by Vitamin D</title><link>/posts/telomeres-which-extend-life-appear-to-be-extended-by-vitamin-d.html</link><pubDate>Wed, 25 Mar 2015 00:00:00 +0000</pubDate><guid>/posts/telomeres-which-extend-life-appear-to-be-extended-by-vitamin-d.html</guid><description>&lt;p>&lt;strong>&lt;span style="color:#00F;">Update: Telemeres in boys were 2.5% longer if 9 ng higher vitamin D – July 2018&lt;/span>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Vitamin D as predictor of telomere length in the transition from child to adolescent&lt;/strong>&lt;/p>
&lt;p>Revue d&amp;rsquo;Épidémiologie et de Santé Publique, Volume 66, Supplement 5, July 2018, Page S237, &lt;a href="https://doi.org/10.1016/j.respe.2018.05.015">https://doi.org/10.1016/j.respe.2018.05.015&lt;/a>&lt;/p>
&lt;p>Van AartaN. MichelsaI.SioenabD .MartenscT.NawrotcS.De Henauwa&lt;/p>
&lt;p>Results&lt;/p>
&lt;p>Telomere length was shorter with increasing age (P = 0.01). Vitamin D was not associated with telomere length in cross-sectional analysis combining both sexes, but in boys higher vitamin D was related to longer telomeres. An interquartile increase in vitamin D (9.4 ng/mL) was associated with a 2.5% (95% confidence interval: 0.1 to 4.9%; P = 0.04) increase in telomere length. Longitudinal analysis showed similar results for boys (P = 0.02).&lt;/p></description></item><item><title>Continuing Medical Education (CME) for Vitamin D includes genes and questions</title><link>/posts/continuing-medical-education-cme-for-vitamin-d-includes-genes-and-questions.html</link><pubDate>Sun, 01 Feb 2015 00:00:00 +0000</pubDate><guid>/posts/continuing-medical-education-cme-for-vitamin-d-includes-genes-and-questions.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-ds-role-in-health--deterministic-or-indeterminate---2014">Vitamin D’s Role in Health — Deterministic or Indeterminate? - 2014&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#10-multiple-choice-questions">10 multiple choice questions&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#1-vitamin-d-is-considered-to-be-which-of-the-following">1. Vitamin D is considered to be which of the following?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#2-which-of-the-following-genetic-mutations-can-result-in-normal-levels-of">2. Which of the following genetic mutations can result in normal levels of&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#3-vitamin-d-testing-specifically-is-recommended-for-which-of-the-following-groups">3. Vitamin D testing specifically is recommended for which of the following groups?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#4-which-of-the-following-is-the-active-form-of-vitamin-d-in-the-body">4. Which of the following is the active form of vitamin D in the body?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#5-beyond-bone-health-vitamin-d-seems-to-help-maintain-health-in-which-of-the-following-ways">5. Beyond bone health, vitamin D seems to help maintain health in which of the following ways?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#6-which-of-the-following-foods-has-the-highest-content-of-vitamin-d-per-serving">6. Which of the following foods has the highest content of vitamin D per serving?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#7-the-sun-is-too-low-during-the-winter-months-to-produce-any-vitamin-d">7. The sun is too low during the winter months to produce any vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#8-vitamin-d-is-associated-with-bone-health-because-it-does-which-of-the-following">8. Vitamin D is associated with bone health because it does which of the following?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#9-the-institute-of-medicine-identifies-vitamin-d-deficiency">9. The Institute of Medicine identifies vitamin D deficiency&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#10-each-serving-of-foods-fortified-with-vitamin-d-contain-approximately-which-of-the-following-amounts">10. Each serving of foods fortified with vitamin D contain approximately which of the following amounts?&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-ds-role-in-health--deterministic-or-indeterminate---2014">Vitamin D’s Role in Health — Deterministic or Indeterminate? - 2014&lt;/h4>
&lt;p>&lt;strong>&lt;a href="http://www.todaysdietitian.com/newarchives/070114p48.shtml">URL&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Diseases, Vitamin D Receptor and other genes</title><link>/posts/diseases-vitamin-d-receptor-and-other-genes.html</link><pubDate>Tue, 13 Jan 2015 00:00:00 +0000</pubDate><guid>/posts/diseases-vitamin-d-receptor-and-other-genes.html</guid><description>&lt;h4 id="an-integrated-approach-to-defining-genetic-and-environmental-determinants-for-major-clinical-outcomes-involving-vitamin-d">An integrated approach to defining genetic and environmental determinants for major clinical outcomes involving vitamin D.&lt;/h4>
&lt;p>Mol Diagn Ther. 2014 Jun;18(3):261-72. &lt;a href="https://doi.org/10.1007/s40291-014-0087-2.">doi: 10.1007/s40291-014-0087-2.&lt;/a>&lt;/p>
&lt;p>Berlanga-Taylor AJ1, Knight JC.&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/determinants.jpg" alt="image">
&lt;p>There is substantial genetic and epidemiological evidence implicating vitamin D in the pathogenesis of many common diseases. A number of studies have sought to define an association for disease with sequence variation in the VDR gene, encoding the ligand-activated nuclear hormone receptor for vitamin D. The results of such studies have been difficult to replicate and are likely to need to account for specific environmental exposures. Here, we review recent work that has begun to study the interactions between VDR gene polymorphisms, vitamin D blood levels, and complex disease susceptibility, notably in the context of major clinical outcomes. We highlight the challenges moving forward in this area and its importance for effective clinical translation of current research.&lt;/p></description></item><item><title>Genes account for less than 18 percent of variation in vitamin D levels</title><link>/posts/genes-account-for-less-than-18-percent-of-variation-in-vitamin-d-levels.html</link><pubDate>Sat, 03 Jan 2015 00:00:00 +0000</pubDate><guid>/posts/genes-account-for-less-than-18-percent-of-variation-in-vitamin-d-levels.html</guid><description>&lt;h3 id="exploring-the-genetic-architecture-of-circulating-25-hydroxyvitamin-d">Exploring the genetic architecture of circulating 25-hydroxyvitamin D.&lt;/h3>
&lt;p>Genet Epidemiol. 2013 Jan;37(1):92-8. &lt;a href="https://doi.org/10.1002/gepi.21694.">doi: 10.1002/gepi.21694.&lt;/a> Epub 2012 Nov 7.&lt;/p>
&lt;p>Hiraki LT1, Major JM, Chen C, Cornelis MC, Hunter DJ, Rimm EB, Simon KC, Weinstein SJ, Purdue MP, Yu K, Albanes D, Kraft P.&lt;/p>
&lt;p>The primary circulating form of vitamin D is 25-hydroxy vitamin D (25(OH)D), a modifiable trait linked with a growing number of chronic diseases. In addition to environmental determinants of 25(OH)D, including dietary sources and skin ultraviolet B (UVB) exposure, twin- and family-based studies suggest that genetics contribute substantially to vitamin D variability with heritability estimates ranging from 43% to 80%. Genome-wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) located in four gene regions associated with 25(OH)D. These SNPs collectively explain only a fraction of the heritability in 25(OH)D estimated by twin- and family-based studies. Using 25(OH)D concentrations and GWAS data on 5,575 subjects drawn from five cohorts, we hypothesized that genome-wide data, in the form of (1) a polygenic score comprised of hundreds or thousands of SNPs that do not individually reach GWAS significance, or (2) a linear mixed model for genome-wide complex trait analysis, would explain variance in measured circulating 25(OH)D beyond that explained by known genome-wide significant 25(OH)D-associated SNPs. GWAS identified SNPs explained 5.2% of the variation in circulating 25(OH)D in these samples and there was little evidence additional markers significantly improved predictive ability. On average, a polygenic score comprised of GWAS-identified SNPs explained a larger proportion of variation in circulating 25(OH)D than scores comprised of thousands of SNPs that were on average, nonsignificant. Employing a linear mixed model for genome-wide complex trait analysis explained little additional variability (range 0-22%). The absence of a significant polygenic effect in this relatively large sample suggests an oligogenetic architecture for 25(OH)D.&lt;/p></description></item><item><title>Genome-wide view on the physiology of vitamin D – ebook</title><link>/posts/genome-wide-view-on-the-physiology-of-vitamin-d-ebook.html</link><pubDate>Sat, 06 Dec 2014 00:00:00 +0000</pubDate><guid>/posts/genome-wide-view-on-the-physiology-of-vitamin-d-ebook.html</guid><description>&lt;p>Frontiers Media SA, ISBN: 978-2-88919-349-3 ebook&lt;/p>
&lt;p>Edited by: Carsten Carlberg&lt;/p>
&lt;h4 id="195-pages">195 pages&lt;/h4>
&lt;ul>
&lt;li>05 The Physiology of Vitamin D—Far More than Calcium and Bone,&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>    Carsten Carlberg&lt;/p>
&lt;/blockquote>
&lt;ul>
&lt;li>07	Genome-Wide (Over)View on the Actions of Vitamin D&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>    Carsten Carlberg&lt;/p>
&lt;/blockquote>
&lt;ul>
&lt;li>17 Structural Considerations of Vitamin D Signaling&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>    Ferdinand Molnar&lt;/p>
&lt;/blockquote>
&lt;ul>
&lt;li>39	Vitamin D and the RNA Transcriptome: More than mRNA Regulation&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>    Moray J. Campbell&lt;/p>
&lt;/blockquote>
&lt;ul>
&lt;li>52 Interaction of Vitamin D with Membrane-Based Signaling Pathways&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>    Maria Jesus Larriba, Jose Manuel Gonzalez-Sancho, Felix Bonilla and Alberto Munoz&lt;/p></description></item><item><title>Breast Cancer rate reduced 72 percent by vitamin D gene polymorphism CYP24A1</title><link>/posts/breast-cancer-rate-reduced-72-percent-by-vitamin-d-gene-polymorphism-cyp24a1.html</link><pubDate>Wed, 26 Nov 2014 00:00:00 +0000</pubDate><guid>/posts/breast-cancer-rate-reduced-72-percent-by-vitamin-d-gene-polymorphism-cyp24a1.html</guid><description>&lt;h4 id="vitamin-d-related-gene-polymorphisms-plasma-25-hydroxyvitamin-d-and-breast-cancer-risk">Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk.&lt;/h4>
&lt;p>Cancer Causes Control. 2014 Nov 25. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Reimers LL1, Crew KD, Bradshaw PT, Santella RM, Steck SE, Sirosh I, Terry MB, Hershman DL, Shane E, Cremers S, Dworakowski E, Teitelbaum SL, Neugut AI, Gammon MD.&lt;/p>
&lt;p>Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 W 168th St, 7th Floor, New York, NY, 10032, USA, &lt;a href="mailto:llr2124@columbia.edu">llr2124@columbia.edu&lt;/a>.&lt;/p></description></item><item><title>Increased mortality associated with low vitamin D genes</title><link>/posts/increased-mortality-associated-with-low-vitamin-d-genes.html</link><pubDate>Wed, 19 Nov 2014 00:00:00 +0000</pubDate><guid>/posts/increased-mortality-associated-with-low-vitamin-d-genes.html</guid><description>&lt;h3 id="genetically-low-vitamin-d-concentrations-and-increased-mortality-mendelian-randomisation-analysis-in-three-large-cohorts">Genetically low vitamin D concentrations and increased mortality: mendelian randomisation analysis in three large cohorts&lt;/h3>
&lt;p>BMJ 2014; 349 &lt;a href="https://doi.org/http">doi: http&lt;/a>://dx.doi.org/10.1136/bmj.g6330 (Published 18 November 2014)&lt;/p>
&lt;p>Shoaib Afzal, registrar12, Peter Brøndum-Jacobsen, registrar12, Stig E Bojesen, professor123, Børge G Nordestgaard, professor123 &lt;a href="mailto:Boerge.Nordestgaard@regionh.dk">Boerge.Nordestgaard@regionh.dk&lt;/a>&lt;/p>
&lt;p>Objective To test the hypothesis that genetically low 25-hydroxyvitamin D concentrations are associated with increased mortality.&lt;/p>
&lt;p>Design &lt;strong>Mendelian randomisation analysis.&lt;/strong>&lt;/p>
&lt;p>Note: the editorial in the same issues, further down this page, describes Mendelian randomisation techniques&lt;/p></description></item><item><title>Some people need more vitamin D to get the same response – perhaps due to genes</title><link>/posts/some-people-need-more-vitamin-d-to-get-the-same-response-perhaps-due-to-genes.html</link><pubDate>Tue, 18 Nov 2014 00:00:00 +0000</pubDate><guid>/posts/some-people-need-more-vitamin-d-to-get-the-same-response-perhaps-due-to-genes.html</guid><description>&lt;h4 id="dissecting-high-from-low-responders-in-a-vitamin-d3-intervention-study">Dissecting high from low responders in a vitamin D3 intervention study&lt;/h4>
&lt;p>The Journal of Steroid Biochemistry and Molecular Biology doi:10.1016/j.jsbmb.2014.11.012&lt;/p>
&lt;p>Noora Saksaa, 1, Antonio Nemea, 1, Jussi Ryynänena, Matti Uusitupab, Vanessa D.F. de Mellob, Sari Voutilainenb, Tarja Nurmib, Jyrki K. Virtanenb, Tomi-Pekka Tuomainenb, Carsten Carlberg a, ,&lt;/p>
&lt;p>&lt;strong>Highlights&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>The genes ASAP2, CAMP, CD14, CD97, DUSP10, G0S2, IL8, LRRC8A, NINJ1, NRIP1, SLC37A2 and THBD are primary VDR targets.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>On the level of the expression of primary VDR target genes only 55–62% of the study participants were vitamin D3 responders.&lt;/p></description></item><item><title>Strong Vitamin D deficiency associations in Asthma patients</title><link>/posts/strong-vitamin-d-deficiency-associations-in-asthma-patients.html</link><pubDate>Tue, 18 Nov 2014 00:00:00 +0000</pubDate><guid>/posts/strong-vitamin-d-deficiency-associations-in-asthma-patients.html</guid><description>&lt;h3 id="p48prevalence-and-determinants-of-vitamin-d-deficiency-in-asthma-patients">P48 Prevalence And Determinants Of Vitamin D Deficiency In Asthma Patients&lt;/h3>
&lt;p>Thorax 2014;69:A94-A95 doi:10.1136/thoraxjnl-2014-206260.189&lt;/p>
&lt;p>Asthma: investigation and organisation of care&lt;/p>
&lt;p>DA Jolliffe 1, AR Martineau 1, BM Maclaughlin 1, KK Kiplin 1, PMT Timms 2, CAM Mein 1, RW Walton 1, CJG Griffiths 1&lt;/p>
&lt;p>1 Queen Mary University of London, London, UK&lt;/p>
&lt;p>2 Homerton University Hospital, London, UK&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/asthma-sci-hub.pdf">Download the PDF from Sci-Hub via VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;p>Background Vitamin D deficiency has been reported to associate with susceptibility to acute respiratory infections and exacerbations in asthma patients. Studies investigating the prevalence and determinants of vitamin D deficiency among asthma patients in the UK are lacking.&lt;/p></description></item><item><title>Multiple Sclerosis is connected to Vitamin D by gene to gene interactions</title><link>/posts/multiple-sclerosis-is-connected-to-vitamin-d-by-gene-to-gene-interactions.html</link><pubDate>Tue, 07 Oct 2014 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-is-connected-to-vitamin-d-by-gene-to-gene-interactions.html</guid><description>&lt;h3 id="molecular-mechanism-underlying-the-impact-of-vitamin-d-on-disease-activity-of-ms">Molecular mechanism underlying the impact of vitamin D on disease activity of MS.&lt;/h3>
&lt;p>Ann Clin Transl Neurol. 2014 Aug;1(8):605-17. &lt;a href="https://doi.org/10.1002/acn3.91.">doi: 10.1002/acn3.91.&lt;/a> Epub 2014 Aug 22.&lt;/p>
&lt;p>Munger KL1, Köchert K2, Simon KC1, Kappos L3, Polman CH4, Freedman MS5, Hartung HP6, Miller DH7, Montalbán X8, Edan G9, Barkhof F4, Pleimes D2, Sandbrink R10, Ascherio A1, Pohl C11.&lt;/p>
&lt;p>Author information&lt;/p>
&lt;p>1Harvard School of Public Health Boston, Massachusetts.&lt;/p>
&lt;p>2Bayer HealthCare Berlin, Germany.&lt;/p>
&lt;p>3University Hospital Basel Basel, Switzerland.&lt;/p></description></item><item><title>Multiple Sclerosis, gene expression, and vitamin D: Venn diagrams</title><link>/posts/multiple-sclerosis-gene-expression-and-vitamin-d-venn-diagrams.html</link><pubDate>Tue, 26 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-gene-expression-and-vitamin-d-venn-diagrams.html</guid><description>&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/mechanism-ms.jpg" alt="image">
&lt;h3 id="molecular-mechanism-underlying-the-impact-of-vitamin-d-on-disease-activity-of-ms">Molecular mechanism underlying the impact of vitamin D on disease activity of MS&lt;/h3>
&lt;p>Annals of Clinical and Translational Neurology, Article first published online: 22 AUG 2014&lt;/p>
&lt;p>Kassandra L. Munger 1,†,*, Karl Köchert 2,†, Kelly C. Simon 1, Ludwig Kappos 3, Chris H. Polman 4, Mark S. Freedman 5, Hans P. Hartung 6, David H. Miller 7, Xavier Montalbán 8, Gilles Edan9, Frederik Barkhof4, Dirk Pleimes2, Rupert Sandbrink2,6, Alberto Ascherio1 and Christoph Pohl2,10&lt;/p></description></item><item><title>Tuberculosis, Genes, Vitamin D Binding Protein, and RCT – Review</title><link>/posts/tuberculosis-genes-vitamin-d-binding-protein-and-rct-review.html</link><pubDate>Mon, 18 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-genes-vitamin-d-binding-protein-and-rct-review.html</guid><description>&lt;h4 id="vitamin-d-status-receptor-gene-polymorphisms-and-supplementation-on-tuberculosis">Vitamin D Status, Receptor Gene Polymorphisms, and Supplementation on Tuberculosis:&lt;/h4>
&lt;p>A Systematic Review of Case-Control Studies and Randomized Controlled Trials&lt;/p>
&lt;p>Journal of Clinical &amp;amp; Translational Endocrinology, DOI: &lt;a href="http://dx.doi.org/10.1016/j.jcte.2014.08.001">http://dx.doi.org/10.1016/j.jcte.2014.08.001&lt;/a>&lt;/p>
&lt;p>Nilay Sutariaemail, Ching-Ti Liuemail, Tai C. Chenemail&lt;/p>
&lt;p>Received: May 23, 2014; Received in revised form: July 25, 2014; Accepted: August 7, 2014; Published Online: August 15, 2014&lt;/p>
&lt;h3 id="highlights">Highlights:&lt;/h3>
&lt;p>•Lower serum 25-hydroxyvitamin D increases susceptibility to tuberculosis.&lt;/p>
&lt;p>•BsmI and FokI VDR gene polymorphisms may confer increased risk of acquiring tuberculosis.&lt;/p></description></item><item><title>UVB increases vitamin D even if poor kidney by changing CYP27B1 genes in skin</title><link>/posts/uvb-increases-vitamin-d-even-if-poor-kidney-by-changing-cyp27b1-genes-in-skin.html</link><pubDate>Wed, 13 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/uvb-increases-vitamin-d-even-if-poor-kidney-by-changing-cyp27b1-genes-in-skin.html</guid><description>&lt;h4 id="a-narrow-band-ultraviolet-b-course-improves-vitamin-d-balance-and-alters-cutaneous-cyp27a1-and-cyp27b1-mrna-expression-levels-in-haemodialysis-patients-supplemented-with-oral-vitamin-d">A narrow-band ultraviolet B course improves vitamin D balance and alters cutaneous CYP27A1 and CYP27B1 mRNA expression levels in haemodialysis patients supplemented with oral vitamin D.&lt;/h4>
&lt;p>Nephron Clin Pract. 2013;124(1-2):17-22. &lt;a href="https://doi.org/10.1159/000355010.">doi: 10.1159/000355010.&lt;/a> Epub 2013 Sep 12.&lt;/p>
&lt;p>Ala-Houhala MJ1, Vähävihu K, Snellman E, Hasan T, Kautiainen H, Karisola P, Dombrowski Y, Schauber J, Saha H, Reunala T.&lt;/p>
&lt;p>Department of Dermatology, Tampere University Hospital, Tampere, Finland&lt;/p>
&lt;p>BACKGROUND/AIMS:&lt;/p>
&lt;p>Chronic kidney disease (CKD) patients on dialysis are prone to vitamin D insufficiency despite oral vitamin D supplementation. Here, we studied whether narrow-band ultraviolet B (NB-UVB) exposures improve vitamin D balance.&lt;/p></description></item><item><title>Pancreatic Cancer massively deregulates the local Vitamin D receptors and CPY24A1</title><link>/posts/pancreatic-cancer-massively-deregulates-the-local-vitamin-d-receptors-and-cpy24a1.html</link><pubDate>Thu, 31 Jul 2014 00:00:00 +0000</pubDate><guid>/posts/pancreatic-cancer-massively-deregulates-the-local-vitamin-d-receptors-and-cpy24a1.html</guid><description>&lt;h3 id="the-vitamin-d-system-is-deregulated-in-pancreatic-diseases">The vitamin D system is deregulated in pancreatic diseases&lt;/h3>
&lt;p>The Journal of Steroid Biochemistry and Molecular Biology, online 30 July 2014, DOI: 10.1016/j.jsbmb.2014.07.011&lt;/p>
&lt;p>Doris Hummela, 1, Abhishek Aggarwala, 1, Katalin Borkab, Erika Bajnaa, Enikö Kállaya, , , Henrik Csaba Horvathc&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/pancreatic-cancer-f1.jpg" alt="image" width="700">
&lt;p>        shaded text and numbers in the chart were added by VitaminDWiki&lt;/p>
&lt;h4 id="highlights">Highlights&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>During PDAC development CYP24A1 levels are reduced in the endocrine islets.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>During malignant transformation pancreatic ducts accumulate CYP24A1 protein.&lt;/p></description></item><item><title>Response to 1000 IU of vitamin D varies by about 4 percent due to gene variants – RCT</title><link>/posts/response-to-1000-iu-of-vitamin-d-varies-by-about-4-percent-due-to-gene-variants-rct.html</link><pubDate>Wed, 30 Jul 2014 00:00:00 +0000</pubDate><guid>/posts/response-to-1000-iu-of-vitamin-d-varies-by-about-4-percent-due-to-gene-variants-rct.html</guid><description>&lt;h4 id="genetic-variants-in-cyp2r1-cyp24a1-and-vdr-modify-the-efficacy-of-vitamin-d3-supplementation-for-increasing-serum-25-hydroxyvitamin-d-levels-in-a-randomized-controlled-trial">Genetic Variants in CYP2R1, CYP24A1 and VDR Modify the Efficacy of Vitamin D3 Supplementation for Increasing Serum 25-Hydroxyvitamin D Levels in a Randomized Controlled Trial.&lt;/h4>
&lt;p>J Clin Endocrinol Metab. 2014 Jul 29:jc20141389. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Barry EL1, Rees JR, Peacock JL, Mott LA, Amos CI, Bostick RM, Figueiredo JC, Ahnen DJ, Bresalier RS, Burke CA, Baron JA.&lt;/p>
&lt;p>Author information&lt;/p>
&lt;p>Context: Adequate serum 25-hydroxyvitamin D concentrations &lt;span>[25(OH)D]&lt;/span> are required for optimal bone health, and low levels are associated with chronic diseases.&lt;/p></description></item><item><title>Genes and Vitamin D - Malacards</title><link>/posts/genes-and-vitamin-d-malacards.html</link><pubDate>Mon, 21 Jul 2014 00:00:00 +0000</pubDate><guid>/posts/genes-and-vitamin-d-malacards.html</guid><description>&lt;h3 id="malacards---vitamin-dhttpwwwmalacardsorgsearchresults22vitamin20d22-describes-each-disease-and-shows-genes-identified-with-it-and-the-top-20-disease-related-to-those-genes">&lt;a href="http://www.malacards.org/search/results/%22vitamin%20d%22">Malacards - Vitamin D&lt;/a> Describes each disease and shows genes identified with it and the top 20 disease related to those genes&lt;/h3>
&lt;h3 id="multiple-sclerosis-ms-maladyhttpwwwmalacardsorgcardmultiple_sclerosissearch22vitamind22-malacards-has-the-following-graphic">&lt;a href="http://www.malacards.org/card/multiple_sclerosis?search=%22vitamin+d%22">Multiple Sclerosis (MS) malady&lt;/a> Malacards has the following graphic&lt;/h3>
&lt;p>&lt;strong>Top 20 diseases related by genes to MS ( many of which are associated with low vitamin D)&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/ms-top-20-gene-related-diseases.jpg" alt="image">
&lt;h3 id="rickets-maladyhttpwwwmalacardsorgcardricketssearch22vitamind22-malacards---has-the-following-chart">&lt;a href="http://www.malacards.org/card/rickets?search=%22vitamin+d%22">Rickets malady&lt;/a> Malacards - has the following chart&lt;/h3>
&lt;p>&lt;strong>Top 20 diseases related to Rickets by genes (many of which are associated with low vitamin D&lt;/strong>&lt;/p></description></item><item><title>Genes (CYP2R1 and GC) which restrict the amount of Vitamin D which gets into bloodstream</title><link>/posts/genes-cyp2r1-and-gc-which-restrict-the-amount-of-vitamin-d-which-gets-into-bloodstream.html</link><pubDate>Tue, 15 Jul 2014 00:00:00 +0000</pubDate><guid>/posts/genes-cyp2r1-and-gc-which-restrict-the-amount-of-vitamin-d-which-gets-into-bloodstream.html</guid><description>&lt;p>&lt;strong>Real-life use of vitamin D3-fortified bread and milk during a winter season: the effects of CYP2R1 and GC genes on 25-hydroxyvitamin D concentrations in Danish families, the VitmaD study&lt;/strong>&lt;/p>
&lt;p>Studying the relationship between genetics and nutrition in the improvement of human health&lt;/p>
&lt;p>Genes &amp;amp; Nutrition © The Author(s) 2014, 10.1007/s12263-014-0413-7&lt;/p>
&lt;p>Janna Nissen1 &lt;a href="mailto:ioni@food.dtu.dk">ioni@food.dtu.dk&lt;/a>, Ulla Vogel2, Gitte Ravn-Haren3, Elisabeth W. Andersen4, Bjørn A. Nexø5, Rikke Andersen1, Heddie Mejborn1, Katja H. Madsen1 and Lone B. Rasmussen1&lt;/p></description></item><item><title>Parkinson’s Disease – no association found with changes in Vitamin D genes – meta-analysis</title><link>/posts/parkinsons-disease-no-association-found-with-changes-in-vitamin-d-genes-meta-analysis.html</link><pubDate>Tue, 01 Jul 2014 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-no-association-found-with-changes-in-vitamin-d-genes-meta-analysis.html</guid><description>&lt;h4 id="association-between-vitamin-d-receptor-gene-polymorphisms-and-susceptibility-to-parkinsons-disease-a-meta-analysis">Association between vitamin D receptor gene polymorphisms and susceptibility to Parkinson&amp;rsquo;s disease: A meta-analysis&lt;/h4>
&lt;p>Neuroscience Letters, online 30 June 2014, DOI: 10.1016/j.neulet.2014.06.051&lt;/p>
&lt;p>Zhang Zitenga, 1, He Yichuanb, 1, Ma Xiujuana, Li Dianyoub, Lu Guocaia,&lt;/p>
&lt;p>Corresponding author. 800 Xiangyin Road, Yangpu District, Shanghai, P.R. China, 200433. Tel.: +8615002178993. &lt;a href="mailto:newdrug@smmu.edu.cn">newdrug@smmu.edu.cn&lt;/a>&lt;/p>
&lt;p>1 These two authors contributed equally to this work.&lt;/p>
&lt;p>&lt;strong>Highlights&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>This meta-analysis focused on the association between the vitamin d receptor gene polymorphism and the PD risk.&lt;/p></description></item><item><title>Role of Vitamin D in human Diseases and Disorders – An Overview – DBP, VDR</title><link>/posts/role-of-vitamin-d-in-human-diseases-and-disorders-an-overview-dbp-vdr.html</link><pubDate>Sun, 29 Jun 2014 00:00:00 +0000</pubDate><guid>/posts/role-of-vitamin-d-in-human-diseases-and-disorders-an-overview-dbp-vdr.html</guid><description>&lt;p>International Journal of Pharmacological Research, Vol 4, No 2 (2014)&lt;/p>
&lt;p>Priyanshee Gohil, Palak Solanki&lt;/p>
&lt;p>Priyanshee Gohil, Assistant Professor, K.B.Institute of Pharmaceutical Education and Research, Gandhinagar, Gujarat, India&lt;/p>
&lt;p>Palak Solanki. Department of Pharmacology and Clinical Pharmacy, K. B. Instituteof Pharmaceutical Education &amp;amp; Research, Kadi SarvaVishvavidyalya, Gandhinagar.	 India&lt;/p>
&lt;p>Vitamin D is a fat soluble vitamin and generated in human skin by ultraviolet (UV) light. Today, vitamin D is considered to be a steroidal hormone and plays a central role in bone mineralization and calcium homeostasis. The active form of the vitamin D is 1, 25-dihydroxyvitamin D &lt;span>[1, 25-dihydroxycholecalciferol (DHCC)]&lt;/span> which mediates proliferation, differentiation and various functions at the cellular level through Vitamin D receptors (VDR).Therefore, compromised vitamin D status is likely to be involved in progression or pathogenesis of various disorders. This assumption is consistent with findings from epidemiological studies that a compromised vitamin D status in humans increases the risk of autoimmune diseases, such as inflammatory bowel disease, rheumatoid arthritis, systemic lupus erythematosus (SLE), multiple sclerosis and type I diabetes mellitus. However, diseases like cancer, cardiovascular disorders and bone disorders are yet not focused. Thus the role of vitamin D in pathogenesis of various diseases is complex and controversial. This review briefly summarizes the role of vitamin D in development and progression of different human disorders.&lt;/p></description></item><item><title>Hypertension associated with genes which reduce vitamin D – meta-analysis</title><link>/posts/hypertension-associated-with-genes-which-reduce-vitamin-d-meta-analysis.html</link><pubDate>Thu, 26 Jun 2014 00:00:00 +0000</pubDate><guid>/posts/hypertension-associated-with-genes-which-reduce-vitamin-d-meta-analysis.html</guid><description>&lt;h4 id="association-of-vitamin-d-status-with-arterial-blood-pressure-and-hypertension-risk-a-mendelian-randomisation-study">Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study&lt;/h4>
&lt;p>The Lancet Diabetes &amp;amp; Endocrinology, Early Online Publication, 26 June 2014, doi:10.1016/S2213-8587(14)70113-5&lt;/p>
&lt;p>study leader Professor Elina Hyppönen from the University of South Australia (Huge list of authors)&lt;/p>
&lt;p>Background&lt;/p>
&lt;p>Low plasma 25-hydroxyvitamin D (25&lt;span>[OH]&lt;/span>D) concentration is associated with high arterial blood pressure and hypertension risk, but whether this association is causal is unknown. We used a mendelian randomisation approach to test whether 25(OH)D concentration is causally associated with blood pressure and hypertension risk.&lt;/p></description></item><item><title>Genome-wide view on the physiology of vitamin D</title><link>/posts/genome-wide-view-on-the-physiology-of-vitamin-d.html</link><pubDate>Tue, 03 Jun 2014 00:00:00 +0000</pubDate><guid>/posts/genome-wide-view-on-the-physiology-of-vitamin-d.html</guid><description>&lt;p>Frontiers In Physiology – Integrative Physiology&lt;/p>
&lt;p>Topic Editors: Carsten Carlberg, University of Eastern Finland, Finland&lt;/p>
&lt;p>The main physiological actions of the biologically most active metabolite of vitamin D, 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3), are calcium and phosphorus uptake and transport and thereby controlling bone formation. Other emergent areas of 1α,25(OH)2D3 action are in the control of immune functions, cellular growth and differentiation. This fits both with the widespread expression of the VDR and the above described consequences of vitamin D deficiency. Transcriptome-wide analysis indicated that per cell type between 200 and 600 genes are primary targets of vitamin D. Since most of these genes respond to vitamin D in a cell-specific fashion, the total number of vitamin D targets in the human genome is far higher than 1,000. This is supported by the genome-wide view on VDR binding sites in human lymphocytes, monocytes, colon and hepatic cells. All genomic actions of 1α,25(OH)2D3 are mediated by the transcription factor vitamin D receptor (VDR) that has been the subject of intense study since the 1980’s. Thus, vitamin D signaling primarily implies the molecular actions of the VDR. In this research topic, we present different perspectives on the action of vitamin D and its receptor, such as the&lt;/p></description></item><item><title>Hypothesis: Early onset Parkinson's (LRRK2) can be prevented with vitamin D</title><link>/posts/hypothesis-early-onset-parkinsons-lrrk2-can-be-prevented-with-vitamin-d.html</link><pubDate>Tue, 03 Jun 2014 00:00:00 +0000</pubDate><guid>/posts/hypothesis-early-onset-parkinsons-lrrk2-can-be-prevented-with-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;/li>
 &lt;li>&lt;a href="#references-on-vitamindwiki">References on VitaminDWiki&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-web">See also web&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h5 id="trialexperiment-details">Trial/Experiment details&lt;/h5>
&lt;p>Recruit from LRRK2 people identified by 23andMe who indicated that they could be contacted (typically 80%)&lt;/p>
&lt;p>Since the high doses of vitamin D are individually adjusted this cannot be a standard RCT trial.&lt;/p>
&lt;p>Also, each participant must have a local doctor who will agree to oversee the trial (Dr. will be paid)&lt;/p>
&lt;p>Click on plus signs in each section to see details&lt;/p></description></item><item><title>Parkinson's disease and LRRK2 gene</title><link>/posts/parkinsons-disease-and-lrrk2-gene.html</link><pubDate>Mon, 02 Jun 2014 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-and-lrrk2-gene.html</guid><description>&lt;p>Note: &lt;strong>Sergey Brin has the LRRK2 gene mutation which is associated with 50% chance of his getting early-onset Parkinson’s Disease in the next 10 years&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#lrrk2-and-neuroinflammation-partners-in-crime-in-parkinsons-disease--march-2014-pdf-attached">LRRK2 and neuroinflammation: partners in crime in Parkinson&amp;rsquo;s disease? – March 2014 PDF attached&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-kinase-lrrk2-mutated-in-parkinsons-disease-is-required-for-vitamin-d3-and-phosphate-metabolism--june-2013">THE KINASE LRRK2, MUTATED IN PARKINSONS DISEASE, IS REQUIRED FOR VITAMIN D3 AND PHOSPHATE METABOLISM = June 2013&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#genetic-insights-into-sporadic-parkinsons-disease-pathogenesis-dec-2013-pdf-attached">Genetic insights into sporadic Parkinson&amp;rsquo;s disease pathogenesis. Dec 2013 PDF attached&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#review-of-early-onset-pd-and-gene-mutations--oct-2012">Review of Early onset PD and gene mutations – Oct 2012&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#what-genetics-tells-us-about-the-causes-and-mechanisms-of-parkinsons-disease--oct-2011-pdf-attached">What genetics tells us about the causes and mechanisms of Parkinson&amp;rsquo;s disease. – Oct 2011 PDF attached&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#what-genetics-tells-us-about-the-causes-decreased-in-rats-with-curcumin-lrrk2-gene--jan-2010">What genetics tells us about the causes decreased in rats with curcumin (LRRK2 gene) – Jan 2010&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#history-of-genetics-and-pd-medscape-2012">History of Genetics and PD: Medscape 2012&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#pmid2019879924">PMID:%2019879924&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#parkinsons-disease-relationship-to-vitamin-dpostsparkinsons-disease-relationship-to-vitamin-d">&lt;a href="/posts/parkinsons-disease-relationship-to-vitamin-d">Parkinson’s Disease relationship to Vitamin D&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#lrrk2-at-genecards---extensive-details">LRRK2 at GeneCards - extensive details&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h3 id="lrrk2-and-neuroinflammation-partners-in-crime-in-parkinsons-disease--march-2014-pdf-attached">LRRK2 and neuroinflammation: partners in crime in Parkinson&amp;rsquo;s disease? – March 2014 PDF attached&lt;/h3>
&lt;p>J Neuroinflammation. 2014 Mar 21;11:52. &lt;a href="https://doi.org/10.1186/1742-2094-11-52.">doi: 10.1186/1742-2094-11-52.&lt;/a>&lt;/p></description></item><item><title>Epigenetics of Multiple Sclerosis</title><link>/posts/epigenetics-of-multiple-sclerosis.html</link><pubDate>Sat, 24 May 2014 00:00:00 +0000</pubDate><guid>/posts/epigenetics-of-multiple-sclerosis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#epigenetics-of-multiple-sclerosis-an-updated-review---2014">Epigenetics of Multiple Sclerosis: An Updated Review - 2014&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="epigenetics-of-multiple-sclerosis-an-updated-review---2014">Epigenetics of Multiple Sclerosis: An Updated Review - 2014&lt;/h4>
&lt;p>NeuroMolecular Medicine March 2014&lt;/p>
&lt;p>Cem İsmail Küçükali, Murat Kürtüncü, Arzu Çoban, Merve Çebi, Erdem Tüzün&lt;/p>
&lt;ol>
&lt;li>
&lt;p>Department of Neuroscience, Institute for Experimental Medicine (DETAE), Istanbul University, Istanbul, Turkey&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey&lt;/p>
&lt;/li>
&lt;/ol>
&lt;p>&lt;a href="mailto:drerdem@yahoo.com">drerdem@yahoo.com&lt;/a>&lt;/p>
&lt;p>Multiple sclerosis (MS) is an inflammatory and neurodegenerative disease characterized with autoimmune response against myelin proteins and progressive axonal loss. The heterogeneity of the clinical course and low concordance rates in monozygotic twins have indicated the involvement of complex heritable and environmental factors in MS pathogenesis. MS is more often transmitted to the next generation by mothers than fathers suggesting an epigenetic influence. One of the possible reasons of this parent-of-origin effect might be the human leukocyte antigen-DRB1*15 allele, which is the major risk factor for MS and regulated by epigenetic mechanisms such as DNA methylation and histone deacetylation. Moreover, major environmental risk factors for MS, vitamin D deficiency, smoking and Ebstein–Barr virus are all known to exert epigenetic changes.&lt;/p></description></item><item><title>Impact of vitamin D on immune function: lessons learned from genome-wide analysis</title><link>/posts/impact-of-vitamin-d-on-immune-function-lessons-learned-from-genome-wide-analysis.html</link><pubDate>Sat, 24 May 2014 00:00:00 +0000</pubDate><guid>/posts/impact-of-vitamin-d-on-immune-function-lessons-learned-from-genome-wide-analysis.html</guid><description>&lt;p>Front Physiol. 2014 Apr 21;5:151. eCollection 2014.&lt;/p>
&lt;p>Chun RF1, Liu PT1, Modlin RL2, Adams JS1, Hewison M1.&lt;/p>
&lt;p>Immunomodulatory responses to the active form of vitamin D (1,25-dihydroxyvitamin D, 1,25D) have been recognized for many years, but it is only in the last 5 years that the potential role of this in normal human immune function has been recognized. Genome-wide analyses have played a pivotal role in redefining our perspective on vitamin D and immunity. The description of increased vitamin D receptor (VDR) and 1α-hydroxylase (CYP27B1) expression in macrophages following a pathogen challenge, has underlined the importance of intracrine vitamin D as key mediator of innate immune function. It is now clear that both macrophages and dendritic cells (DCs) are able to respond to 25-hydroxyvitamin D (25D), the major circulating vitamin D metabolite, thereby providing a link between the function of these cells and the variations in vitamin D status common to many humans. The identification of hundreds of primary 1,25D target genes in immune cells has also provided new insight into the role of vitamin D in the adaptive immune system, such as the modulation of antigen-presentation and T cells proliferation and phenotype, with the over-arching effects being to suppress inflammation and promote immune tolerance. In macrophages 1,25D promotes antimicrobial responses through the induction of antibacterial proteins, and stimulation of autophagy and autophagosome activity. In this way variations in 25D levels have the potential to influence both innate and adaptive immune responses. More recent genome-wide analyses have highlighted how cytokine signaling pathways can influence the intracrine vitamin D system and either enhance or abrogate responses to 25D. The current review will discuss the impact of intracrine vitamin D metabolism on both innate and adaptive immunity, whilst introducing the concept of disease-specific corruption of vitamin D metabolism and how this may alter the requirements for vitamin D in maintaining a healthy immune system in humans.&lt;/p></description></item><item><title>Vitamin D and the epigenome</title><link>/posts/vitamin-d-and-the-epigenome.html</link><pubDate>Sat, 24 May 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-the-epigenome.html</guid><description>&lt;p>Front Physiol. 2014 Apr 29;5:164. eCollection 2014.&lt;/p>
&lt;p>Fetahu IS, Höbaus J, Kállay E.&lt;/p>
&lt;p>Department of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Comprehensive Cancer Center, Medical University of Vienna Vienna, Austria.&lt;/p>
&lt;p>Epigenetic mechanisms play a crucial role in regulating gene expression. The main mechanisms involve methylation of DNA and covalent modifications of histones by methylation, acetylation, phosphorylation, or ubiquitination. The complex interplay of different epigenetic mechanisms is mediated by enzymes acting in the nucleus. Modifications in DNA methylation are performed mainly by DNA methyltransferases (DNMTs) and ten-eleven translocation (TET) proteins, while a plethora of enzymes, such as histone acetyltransferases (HATs), histone deacetylases (HDACs), histone methyltransferases (HMTs), and histone demethylases (HDMs) regulate covalent histone modifications. In many diseases, such as cancer, the epigenetic regulatory system is often disturbed. Vitamin D interacts with the epigenome on multiple levels.&lt;/p></description></item><item><title>Colon cancer more likely in blacks due to differences in Vitamin D genes (wonder if more Vitamin D would help)</title><link>/posts/colon-cancer-more-likely-in-blacks-due-to-differences-in-vitamin-d-genes-wonder--in-d-would-help.html</link><pubDate>Wed, 21 May 2014 00:00:00 +0000</pubDate><guid>/posts/colon-cancer-more-likely-in-blacks-due-to-differences-in-vitamin-d-genes-wonder--in-d-would-help.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#genetic-variation-in-vitamin-d-related-genes-and-risk-of-colorectal-cancer-in-african-americans">Genetic variation in vitamin D-related genes and risk of colorectal cancer in African Americans.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="genetic-variation-in-vitamin-d-related-genes-and-risk-of-colorectal-cancer-in-african-americans">Genetic variation in vitamin D-related genes and risk of colorectal cancer in African Americans.&lt;/h4>
&lt;p>Cancer Causes Control. 2014 May;25(5):561-70. &lt;a href="https://doi.org/10.1007/s10552-014-0361-y.">doi: 10.1007/s10552-014-0361-y.&lt;/a> Epub 2014 Feb 23.&lt;/p>
&lt;p>Pibiri F1, Kittles RA, Sandler RS, Keku TO, Kupfer SS, Xicola RM, Llor X, Ellis NA.&lt;/p>
&lt;p>PURPOSE:&lt;/p>
&lt;p>Disparities in both colorectal cancer (CRC) incidence and survival impact African Americans (AAs) more than other US ethnic groups. Because vitamin D is thought to protect against CRC and AAs have lower serum vitamin D levels, genetic variants that modulate the levels of active hormone in the tissues could explain some of the cancer health disparity. Consequently, we hypothesized that genetic variants in vitamin D-related genes are associated with CRC risk.&lt;/p></description></item><item><title>Colorectal cancer – need more vitamin D if you have certain genes</title><link>/posts/colorectal-cancer-need-more-vitamin-d-if-you-have-certain-genes.html</link><pubDate>Wed, 21 May 2014 00:00:00 +0000</pubDate><guid>/posts/colorectal-cancer-need-more-vitamin-d-if-you-have-certain-genes.html</guid><description>&lt;h4 id="serum-vitamin-d-metabolites-in-colorectal-cancer-patients-receiving-cholecalciferol-supplementation-correlation-with-polymorphisms-in-the-vitamin-d-genes">Serum vitamin D metabolites in colorectal cancer patients receiving cholecalciferol supplementation: correlation with polymorphisms in the vitamin D genes.&lt;/h4>
&lt;p>Horm Cancer. 2013 Aug;4(4):242-50. &lt;a href="https://doi.org/10.1007/s12672-013-0139-9.">doi: 10.1007/s12672-013-0139-9.&lt;/a> Epub 2013 Feb 28.&lt;/p>
&lt;p>Muindi JR, Adjei AA, Wu ZR, Olson I, Huang H, Groman A, Tian L, Singh PK, Sucheston LE, Johnson CS, Trump DL, Fakih MG.&lt;/p>
&lt;p>Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA. &lt;a href="mailto:Josephia.muindi@roswellpark.org">Josephia.muindi@roswellpark.org&lt;/a>&lt;/p>
&lt;p>Cholecalciferol (D(3)) supplementation results in variable increases in serum 25(OH)D(3) levels, however, the influence of genetic polymorphisms on these variable responses is unclear. We measured serum 25(OH)D(3), 24,25(OH)(2)D(3), 1,25(OH)2D(3) and VDBP levels in 50 colorectal cancer (CRC) patients before and during &lt;strong>2,000 IU&lt;/strong> daily oral D(3) supplementation for six months and in 263 archived CRC serum samples. Serum PTH levels and PBMC 24-OHase activity were also measured during D(3) supplementation. TagSNPs in CYP2R1, CYP27A1, CYP27B1, CYP24A1, VDR, and GC genes were genotyped in all patients, and the association between these SNPs and serum vitamin D(3) metabolites levels before and after D(3) supplementation was analyzed. The mean baseline serum 25(OH)D(3) level was less than 32 ng/mL in 65 % of the 313 CRC patients.&lt;/p></description></item><item><title>UVB effects on genes of those with and without Psoriasis</title><link>/posts/uvb-effects-on-genes-of-those-with-and-without-psoriasis.html</link><pubDate>Thu, 17 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/uvb-effects-on-genes-of-those-with-and-without-psoriasis.html</guid><description>&lt;h4 id="narrow-band-ultraviolet-b-treatment-boosts-serum-25-hydroxyvitamin-d-in-patients-with-psoriasis-on-oral-vitamin-d-supplementation">Narrow-band Ultraviolet B Treatment Boosts Serum 25-hydroxyvitamin D in Patients with Psoriasis on Oral Vitamin D Supplementation&lt;/h4>
&lt;p>ACTA Dermato-Venereologica &lt;a href="https://doi.org/10.2340/00015555-1685">doi: 10.2340/00015555-1685&lt;/a>&lt;/p>
&lt;p>Meri J. Ala-Houhala, Toni Karppinen, Katja Vähävihu, Hannu Kautiainen, Yvonne Dombrowski, Erna Snellman, Jürgen Schauber, Timo Reunala&lt;/p>
&lt;p>Department of Dermatology, Tampere University Hospital, FIN-33521 Tampere, Finland&lt;/p>
&lt;p>A course of treatment with narrow-band ultraviolet B (NB-UVB) improves psoriasis and increases serum 25-hydroxyvitamin D (25(OH)D). In this study 12 patients with psoriasis who were supplemented with oral cholecalciferol, 20 µg daily, were given a course of NB-UVB and their response measured. At baseline, serum 25(OH)D was 74.14 ± 22.9 nmol/l. At the 9th exposure to NB-UVB 25(OH)D had increased by 13.2 nmol/l (95% confidence interval (95% CI) 7.2–18.4) and at the 18th exposure by 49.4 nmol/l (95% CI 35.9–64.6) above baseline. Psoriasis Area Severity Index score improved from 8.7 ± 3.5 to 4.5 ± 2.0 (p &amp;lt; 0.001). At baseline, psoriasis lesions showed low vitamin D metabolizing enzyme (CYP27A1, CYP27B1) and high human β-defensin-2 mRNA expression levels compared with those of the healthy subjects. In conclusion, NB-UVB treatment significantly increases serum 25(OH)D in patients with psoriasis who are taking oral vitamin D supplementation, and the concentrations remain far from the toxicity level. Healing psoriasis lesions show similar mRNA expression of vitamin D metabolizing enzymes, but higher antimicrobial peptide levels than NB-UVB-treated skin in healthy subjects.&lt;/p></description></item><item><title>2,776 vitamin D receptor binding sites</title><link>/posts/2776-vitamin-d-receptor-binding-sites.html</link><pubDate>Thu, 10 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/2776-vitamin-d-receptor-binding-sites.html</guid><description>&lt;h3 id="new-study-shows-genetic-link-between-vitamin-d-and-disease-preventionhttpwwwtbyilcomvitamind_genetic_linkhtm--the-best-years-of-your-life">&lt;a href="http://www.tbyil.com/VitaminD_Genetic_Link.htm">New Study Shows Genetic Link Between Vitamin D and Disease Prevention&lt;/a> The best years of your life&lt;/h3>
&lt;p>Discussing a recent publication in Genome Research&lt;/p>
&lt;ul>
&lt;li>&amp;ldquo;The binding sites were found to be unusually concentrated near a number of genes which have been associated with susceptibility to autoimmune conditions such as&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>MS,&lt;/p>
&lt;/blockquote>
&lt;blockquote>
&lt;p>Crohn’s disease,&lt;/p>
&lt;/blockquote>
&lt;blockquote>
&lt;p>lupus and rheumatoid arthritis, as well as to&lt;/p>
&lt;/blockquote>
&lt;blockquote>
&lt;p>cancers such as chronic lymphocytic leukemia and colorectal cancer.&amp;rdquo;&lt;/p>
&lt;/blockquote></description></item><item><title>CYP2R1 gene probably responsible for low vitamin D response – RCT</title><link>/posts/cyp2r1-gene-probably-responsible-for-low-vitamin-d-response-rct.html</link><pubDate>Fri, 04 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/cyp2r1-gene-probably-responsible-for-low-vitamin-d-response-rct.html</guid><description>&lt;h3 id="environmental-personal-and-genetic-determinants-of-response-to-vitamin-d-supplementation-in-older-adults">Environmental, personal and genetic determinants of response to vitamin D supplementation in older adults.&lt;/h3>
&lt;p>J Clin Endocrinol Metab. 2014 Apr 2:jc20134101. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Waterhouse M1, Tran B, Armstrong BK, Baxter C, Ebeling PR, English DR, Gebski V, Hill C, Kimlin MG, Lucas RM, Venn A, Webb PM, Whiteman DC, Neale RE.&lt;/p>
&lt;p>1Population Health Division, QIMR Berghofer Medical Research Institute; Australia&lt;/p>
&lt;p>Context and Objective: Suboptimal vitamin D status can be corrected by vitamin D supplementation, but individual responses to supplementation vary. We aimed to examine genetic and non-genetic determinants of change in serum 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span> following supplementation.&lt;/p></description></item><item><title>Most Autism Risk factors are associated with low vitamin D</title><link>/posts/most-autism-risk-factors-are-associated-with-low-vitamin-d.html</link><pubDate>Sun, 30 Mar 2014 00:00:00 +0000</pubDate><guid>/posts/most-autism-risk-factors-are-associated-with-low-vitamin-d.html</guid><description>&lt;h2 id="how-to-think-about-the-risk-of-autismhttpwwwnytimescom20140330opinionsundayhow-to-think-about-the-risk-of-autismhtml_r0">&lt;a href="http://www.nytimes.com/2014/03/30/opinion/sunday/how-to-think-about-the-risk-of-autism.html?_r=0">How to Think About the Risk of Autism&lt;/a>&lt;/h2>
&lt;p>&lt;strong>New York Times March 29, 2014&lt;/strong>&lt;/p>
&lt;p>No mention of vitamin D in the article&lt;/p>
&lt;p>&lt;strong>VitaminDWiki has highlighted those autism risk factors in the NYT article which are also associated with low levels of Vitamin D&lt;/strong>&lt;/p>
&lt;img src="/attachments/d3.mock.jpg" alt="image"> 
&lt;h4 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/overview-autism-and-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Overview Autism and vitamin D">Overview Autism and vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/having-twins-takes-more-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Having twins takes more vitamin D - May 2011">Having twins takes more vitamin D - May 2011&lt;/a>&lt;/p></description></item><item><title>Melanoma risk 2X to 4X higher if Vitamin D receptor genes had morphed</title><link>/posts/melanoma-risk-2x-to-4x-higher-if-vitamin-d-receptor-genes-had-morphed.html</link><pubDate>Wed, 19 Mar 2014 00:00:00 +0000</pubDate><guid>/posts/melanoma-risk-2x-to-4x-higher-if-vitamin-d-receptor-genes-had-morphed.html</guid><description>&lt;h3 id="melanoma-risk-is-associated-with-vitamin-d-receptor-gene-polymorphisms">Melanoma risk is associated with vitamin D receptor gene polymorphisms&lt;/h3>
&lt;p>Melanoma Res. 2014 Mar 14. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Zeljic K, Kandolf-Sekulovic L, Supic G, Pejovic J, Novakovic M, Mijuskovic Z, Magic Z.&lt;/p>
&lt;p>aLaboratory for Molecular Genetics, Institute for Medical Research&lt;/p>
&lt;p>bClinic for Dermatovenereology&lt;/p>
&lt;p>cCenter for Biochemistry&lt;/p>
&lt;p>dClinic for Plastic Surgery and Burns, Military Medical Academy&lt;/p>
&lt;p>eFaculty of Medicine, Military Medical Academy, University of Defense&lt;/p>
&lt;p>fDepartment of Genetics and Evolution, Faculty of Biology, University of Belgrade, Belgrade, Serbia.&lt;/p></description></item><item><title>Infections, vitamin D and genes – detailed review</title><link>/posts/infections-vitamin-d-and-genes-detailed-review.html</link><pubDate>Sat, 08 Mar 2014 00:00:00 +0000</pubDate><guid>/posts/infections-vitamin-d-and-genes-detailed-review.html</guid><description>&lt;h4 id="differential-expression-of-serumplasma-proteins-in-various-infectious-diseases-specific-or-nonspecific-signatures">Differential expression of serum/plasma proteins in various infectious diseases: Specific or nonspecific signatures&lt;/h4>
&lt;p>Sandipan Ray1, Sandip K. Patel1, Vipin Kumar1, Jagruti Damahe2, Sanjeeva Srivastava1,*&lt;/p>
&lt;p>PROTEOMICS - Clinical Applications. Volume 8, Issue 1-2, pages 53–72, February 2014, DOI: 10.1002/prca.201300074&lt;/p>
&lt;p>Apart from direct detection of the infecting organisms or biomarker of the pathogen itself, surrogate host markers are also useful for sensitive and early diagnosis of pathogenic infections. Early detection of pathogenic infections, discrimination among closely related diseases with overlapping clinical manifestations, and monitoring of disease progression can be achieved by analyzing blood biomarkers. Therefore, over the last decade large numbers of proteomics studies have been conducted to identify differentially expressed human serum/plasma proteins in different infectious diseases with the intent of discovering novel potential diagnostic/prognostic biomarkers. However, in-depth review of the literature indicates that many reported biomarkers are altered in the same way in multiple infectious diseases, regardless of the type of infection. This might be a consequence of generic acute phase reactions, while the uniquely modulated candidates in different pathogenic infections could be indicators of some specific responses. In this review article, we will provide a comprehensive analysis of differentially expressed serum/plasma proteins in various infectious diseases and categorize the protein markers associated with generic or specific responses. The challenges associated with the discovery, validation, and translational phases of serum/plasma biomarker establishment are also discussed.&lt;/p></description></item><item><title>Gene differences can result in 14 ng difference in vitamin D levels</title><link>/posts/gene-differences-can-result-in-14-ng-difference-in-vitamin-d-levels.html</link><pubDate>Tue, 04 Mar 2014 00:00:00 +0000</pubDate><guid>/posts/gene-differences-can-result-in-14-ng-difference-in-vitamin-d-levels.html</guid><description/></item><item><title>Vitamin D and microRNAs in bone</title><link>/posts/vitamin-d-and-micrornas-in-bone.html</link><pubDate>Fri, 28 Feb 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-micrornas-in-bone.html</guid><description>&lt;p>Crit Rev Eukaryot Gene Expr. 2013;23(3):195-214.&lt;/p>
&lt;p>Lisse TS1, Adams JS, Hewison M.&lt;/p>
&lt;p>MicroRNAs (miRNAs) are short noncoding RNAs that orchestrate complex posttranscriptional regulatory networks essential to the regulation of gene expression. Through complementarity with messenger RNA (mRNA) sequences, miRNAs act primarily to silence gene expression through either degradation or inhibited translation of target transcripts. In this way, miRNAs can act to fine-tune the transcriptional regulation of gene expression, but they may also play distinct roles in the proliferation, differentiation, and function of specific cell types. miRNA regulatory networks may be particularly important for signaling molecules such as vitamin D that exert pleiotropic effects on tissues throughout the body.&lt;/p></description></item><item><title>Diabetics with 8ng less vitamin D had a 50 percent increase chance of DHCR7 gene variation</title><link>/posts/diabetics-with-8ng-less-vitamin-d-had-a-50-percent-increase-chance-of-dhcr7-gene-variation.html</link><pubDate>Tue, 28 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/diabetics-with-8ng-less-vitamin-d-had-a-50-percent-increase-chance-of-dhcr7-gene-variation.html</guid><description>&lt;h3 id="vitamin-d-concentration-obesity-and-risk-of-diabetes-a-mendelian-randomisation-study">Vitamin D concentration, obesity, and risk of diabetes: a mendelian randomisation study&lt;/h3>
&lt;p>The Lancet Diabetes &amp;amp; Endocrinology, Available online 28 January 2014&lt;/p>
&lt;p>Shoaib Afzal, PhDa, Peter Brøndum-Jacobsen, MDa, b, Stig E Bojesen, DMSca, b, c, Prof Børge G Nordestgaard, DMSca, b, c, &lt;a href="mailto:boerge.nordestgaard@regionh.dk">boerge.nordestgaard@regionh.dk&lt;/a>&lt;/p>
&lt;p>a The Department of Clinical Biochemistry and The Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark&lt;/p>
&lt;p>b Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark&lt;/p></description></item><item><title>Vitamin D may block the obesity gene (FTO)</title><link>/posts/vitamin-d-may-block-the-obesity-gene-fto.html</link><pubDate>Fri, 24 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-may-block-the-obesity-gene-fto.html</guid><description>&lt;p>&lt;strong>Back in 2010 VitaminDWiki noticed that about 1/3 of the women in a study were able to greatly lose weight by just taking vitamin D: no exercise nor calorie restriction required. Had wondered why. It appears that that the women who lost weight may have had one or two flawed FTO genes&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#toward-personalized-prevention-of-obesity-can-vitamin-d-negate-the-fto-effect">Toward Personalized Prevention of Obesity: Can Vitamin D Negate the FTO Effect?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#fto-genotype-vitamin-d-status-and-weight-gain-during-childhood">FTO Genotype, Vitamin D Status, and Weight Gain During Childhood&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-alsovitamindwiki">See also	VitaminDWiki&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-web">See also web&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h3 id="toward-personalized-prevention-of-obesity-can-vitamin-d-negate-the-fto-effect">Toward Personalized Prevention of Obesity: Can Vitamin D Negate the FTO Effect?&lt;/h3>
&lt;p>Diabetes Volume 63, February 2014 Corinne D. Engelman &lt;a href="mailto:cengelman@wisc.edu">cengelman@wisc.edu&lt;/a>&lt;/p></description></item><item><title>New approaches to bones, genes, and vitamin D</title><link>/posts/new-approaches-to-bones-genes-and-vitamin-d.html</link><pubDate>Fri, 10 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/new-approaches-to-bones-genes-and-vitamin-d.html</guid><description>&lt;h4 id="regulation-of-gene-expression-by-125-dihydroxyvitamin-d3-in-bone-cells-exploiting-new-approaches-and-defining-new-mechanisms">Regulation of gene expression by 1,25-dihydroxyvitamin D3 in bone cells: exploiting new approaches and defining new mechanisms&lt;/h4>
&lt;p>BoneKEy Reports, (2014) 3, Article number: 482 (2014) doi:10.1038/bonekey.2013.216 Jan 2014&lt;/p>
&lt;p>J Wesley Pike,&lt;/p>
&lt;p>Seong Min Lee&lt;/p>
&lt;p>&amp;amp; Mark B Meyer&lt;/p>
&lt;p>The biological actions of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) serve both to orchestrate calcium and phosphorus homeostasis in higher vertebrates and to regulate a diverse set of cellular functions unrelated to control of mineral metabolism. With regard to bone, mesenchymal lineage cells, including both early and late osteoblasts as well as osteocytes represent classic targets of the vitamin D hormone. Accordingly, much of the early information regarding our current understanding of the mechanism of action of 1,25(OH)2D3, of which gene regulation is central, derives from a broad array of studies in these cell types. Indeed, a gene that provided both the earliest and perhaps the most extensive information regarding this and additional mechanisms was that of osteoblast-specific osteocalcin. Subsequent work has provided much additional detail as to how 1,25(OH)2D3, through the vitamin D receptor (VDR), mediates the modulation of many bone cell genes. In recent years, however, a series of technical advances involving the coupling of chromatin immunoprecipitation (ChIP) to unbiased methodologies that involve next-generation DNA sequencing techniques (ChIP-seq) have opened new avenues in the study of gene regulation. In this review, we summarize early work and then focus on more recent studies that have used ChIP-seq analysis and other approaches to provide insight into not only the regulation of specific genes such as the VDR, TNFSF11 (RANKL), LRP5, CBS and CYP24a1, but overarching genome-wide principles of gene regulation as well. The results of these studies highlight the value of these new approaches and the increased insight that can be gained.&lt;/p></description></item><item><title>Vitamin D and its active metabolites – DeLuca</title><link>/posts/vitamin-d-and-its-active-metabolites-deluca.html</link><pubDate>Fri, 10 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-its-active-metabolites-deluca.html</guid><description>&lt;h3 id="history-of-the-discovery-of-vitamin-d-and-its-active-metabolites">History of the discovery of vitamin D and its active metabolites&lt;/h3>
&lt;p>BoneKEy Reports 3, Article number: 479 (2014) | doi:10.1038/bonekey.2013.213 © 2014 International Bone &amp;amp; Mineral Society All rights reserved 2047-6396/14 Hector F DeLuca&lt;/p>
&lt;p>Department of Biochemistry, University of Wisconsin-Madison, Madison, WI, USA. &lt;a href="mailto:deluca@biochem.wisc.edu">deluca@biochem.wisc.edu&lt;/a>&lt;/p>
&lt;p>Before the twentieth century, it was not possible to describe the essentials of a diet that could support life, growth and reproduction of higher animals. The discovery of vitamin A by McCollum and Davis in 1913 ushered in the era of accessory food substances culminating in the achievement of that goal. It included the discovery of vitamin D and its production in skin caused by ultraviolet light. This was followed by a description of its actions at the physiological level that resulted in a healthy skeleton and beyond. To carry out these functions, vitamin D is converted to a hormone that acts through a nuclear receptor. The findings leading to this concept and their importance to biology and medicine are presented.&lt;/p></description></item><item><title>Asthma related to vitamin D by 4 plausible genes</title><link>/posts/asthma-related-to-vitamin-d-by-4-plausible-genes.html</link><pubDate>Wed, 06 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/asthma-related-to-vitamin-d-by-4-plausible-genes.html</guid><description>&lt;h3 id="vitamin-d-related-genes-in-lung-development-and-asthma-pathogenesis">Vitamin D related genes in lung development and asthma pathogenesis.&lt;/h3>
&lt;p>BMC Med Genomics. 2013 Nov 5;6(1):47.&lt;/p>
&lt;p>Kho AT, Sharma S, Qiu W, Gaedigk R, Klanderman B, Niu S, Anderson C, Leeder JS, Weiss ST, Tantisira KG.&lt;/p>
&lt;p>BACKGROUND: Poor maternal vitamin D intake is a risk factor for subsequent childhood asthma, suggesting that in utero changes related to vitamin D responsive genes might play a crucial role in later disease susceptibility. We hypothesized that vitamin D pathway genes are developmentally active in the fetal lung and that these developmental genes would be associated with asthma susceptibility and regulation in asthma.&lt;/p></description></item><item><title>Surprise:Three different types of vitamin D can activate the vitamin D receptor</title><link>/posts/surprisethree-different-types-of-vitamin-d-can-activate-the-vitamin-d-receptor.html</link><pubDate>Sun, 27 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/surprisethree-different-types-of-vitamin-d-can-activate-the-vitamin-d-receptor.html</guid><description>&lt;h4 id="gene-expression-profiles-in-human-and-mouse-primary-cells-provide-new-insights-into-the-differential-actions-of-vitamin-d3-metabolites">Gene Expression Profiles in Human and Mouse Primary Cells Provide New Insights into the Differential Actions of Vitamin D3 Metabolites&lt;/h4>
&lt;p>PLoS ONE 8(10): e75338. doi:10.1371/journal.pone.0075338&lt;/p>
&lt;p>Pentti Tuohimaa, Jing-Huan Wang, Sofia Khan, Marianne Kuuslahti, Kui Qian, Tommi Manninen, Petri Auvinen, Mauno Vihinen, Yan-Ru Lou mail&lt;/p>
&lt;p>1α,25-Dihydroxyvitamin D3 (1α,25(OH)2D3) had earlier been regarded as the only active hormone.&lt;/p>
&lt;p>The newly identified actions of 25-hydroxyvitamin D3 (25(OH)D3) and 24R,25-dihydroxyvitamin D3 (24R,25(OH)2D3) broadened the vitamin D3 endocrine system, however, the current data are fragmented and a systematic understanding is lacking. Here we performed the first systematic study of global gene expression to clarify their similarities and differences.&lt;/p></description></item><item><title>Activation (methylation) of CYP2R1 and CYP24A1 predict response to dose of vitamin D</title><link>/posts/activation-methylation-of-cyp2r1-and-cyp24a1-predict-response-to-dose-of-vitamin-d.html</link><pubDate>Thu, 17 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/activation-methylation-of-cyp2r1-and-cyp24a1-predict-response-to-dose-of-vitamin-d.html</guid><description>&lt;h3 id="dna-methylation-levels-of-cyp2r1-and-cyp24a1-predict-vitamin-d-response-variation">DNA Methylation Levels of CYP2R1 and CYP24A1 Predict Vitamin D Response Variation&lt;/h3>
&lt;p>The Journal of Steroid Biochemistry and Molecular Biology. online 12 October 2013&lt;/p>
&lt;p>Yu Zhouc, d, e, 1, Lan-Juan Zhaoc, f, 1 &lt;a href="mailto:lzhao2@tulane.edu">lzhao2@tulane.edu&lt;/a>, Xiaojing Xuc, f,&lt;/p>
&lt;p>An Yec, f, Dianne Travers-Gustafson f, Boting Zhou e, Hong-Wei Wang g,&lt;/p>
&lt;p>Weidong Zhangc, L. Lee Hamm h, Hong-Wen Deng c, Robert R. Recker f, &lt;strong>Joan M. Lappe&lt;/strong> f&lt;/p>
&lt;p>c Center for Bioinformatics and Genomics, Department of Biostatistics and Bioinformatics, Tulane University, New Orleans, LA, USA, 70112&lt;/p></description></item><item><title>Mice lacking CYP2R1 enzyme activate about half of much vitamin D</title><link>/posts/mice-lacking-cyp2r1-enzyme-activate-about-half-of-much-vitamin-d.html</link><pubDate>Tue, 10 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/mice-lacking-cyp2r1-enzyme-activate-about-half-of-much-vitamin-d.html</guid><description>&lt;h3 id="cyp2r1-is-a-major-but-not-exclusive-contributor-to-25-hydroxyvitamin-d-production-in-vivo">CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo&lt;/h3>
&lt;p>[PNAS September 9, 2013, &lt;a href="https://doi.org/10.1073/pnas.1315006110">doi: 10.1073/pnas.1315006110&lt;/a>](&lt;a href="http://www.pnas.org/content/early/2013/09/04/1315006110.abstract?maxtoshow=&amp;amp;HITS=10&amp;amp;hits=3&amp;amp;RESULTFORMAT=&amp;amp;andorexacttitle=and&amp;amp;titleabstract=vitamin+d&amp;amp;andorexacttitleabs=phrase&amp;amp;andorexactfulltext=and&amp;amp;searchid=1&amp;amp;usestrictdates=yes&amp;amp;resourcetype=HWCIT&amp;amp;ct%20">http://www.pnas.org/content/early/2013/09/04/1315006110.abstract?maxtoshow=&amp;amp;HITS=10&amp;amp;hits=3&amp;amp;RESULTFORMAT=&amp;amp;andorexacttitle=and&amp;amp;titleabstract=vitamin+d&amp;amp;andorexacttitleabs=phrase&amp;amp;andorexactfulltext=and&amp;amp;searchid=1&amp;amp;usestrictdates=yes&amp;amp;resourcetype=HWCIT&amp;amp;ct%20&lt;/a>) $10 for full access&lt;/p>
&lt;p>Jinge G. Zhu a,&lt;/p>
&lt;p>Justin T. Ochalek a,&lt;/p>
&lt;p>Martin Kaufmann b,&lt;/p>
&lt;p>Glenville Jones b, and&lt;/p>
&lt;p>Hector F. DeLuca a &lt;a href="mailto:deluca@biochem.wisc.edu">deluca@biochem.wisc.edu&lt;/a>&lt;/p>
&lt;p>A Department of Biochemistry, University of Wisconsin, Madison, WI 53706; and&lt;/p>
&lt;p>B Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, ON, Canada K7L 3N6&lt;/p>
&lt;p>Significance: Although the vitamin D endocrine system has been well defined and the enzyme responsible for converting 25-hydroxyvitamin D to the final hormone, 1α,25-dihydroxyvitamin D3, is well understood, the enzyme responsible for the conversion of vitamin D to the blood form, 25-hydroxyvitamin D, has not been clearly identified. A case has been made for vitamin D 25-hydroxylase CYP2R1 as the responsible enzyme, but proof is lacking. We have produced a null mutant mouse lacking CYP2R1. With this model, we have shown that CYP2R1 is the major but not exclusive 25-hydroxylase and that there remains another significant enzyme responsible for this step in vitamin D activation that has yet to be identified.&lt;/p></description></item><item><title>Low vitamin D in mother rat altered 426 genes in newborn rat</title><link>/posts/low-vitamin-d-in-mother-rat-altered-426-genes-in-newborn-rat.html</link><pubDate>Thu, 22 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/low-vitamin-d-in-mother-rat-altered-426-genes-in-newborn-rat.html</guid><description>&lt;h4 id="maternal-vitamin-d-deficiency-causes-smaller-muscle-fibers-and-altered-transcript-levels-of-genes-involved-in-protein-degradation-myogenesis-and-cytoskeleton-organization-in-the-newborn-rat">Maternal vitamin D deficiency causes smaller muscle fibers and altered transcript levels of genes involved in protein degradation, myogenesis, and cytoskeleton organization in the newborn rat.&lt;/h4>
&lt;p>Mol Nutr Food Res. 2013 Aug 21. &lt;a href="https://doi.org/10.1002/mnfr.201300360.">doi: 10.1002/mnfr.201300360.&lt;/a>&lt;/p>
&lt;p>Max D, Brandsch C, Schumann S, Kühne H, Frommhagen M, Schutkowski A, Hirche F, Staege MS, Stangl GI.&lt;/p>
&lt;p>Institute of Agricultural and Nutritional Sciences, Martin-Luther-University Halle-Wittenberg, Halle/Saale, Germany.&lt;/p>
&lt;p>SCOPE: Epidemiologic data reveal associations between low serum concentrations of 25-hydroxyvitamin D (25(OH)D) and higher risk of falls and muscle weakness. Fetal stage is critical for the development of skeletal muscle, but little information is available on the impact of maternal vitamin D deficiency on muscles of offspring.&lt;/p></description></item><item><title>RXRA gene activity at birth weakly associated with bone density at age 4</title><link>/posts/rxra-gene-activity-at-birth-weakly-associated-with-bone-density-at-age-4.html</link><pubDate>Thu, 15 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/rxra-gene-activity-at-birth-weakly-associated-with-bone-density-at-age-4.html</guid><description>&lt;h3 id="analysis-of-vitamin-d-related-molecular-switches-predicts-childhood-bone-masshttpwwwbioquicknewscomnode127420-bioquicknews">&lt;a href="http://www.bioquicknews.com/node/1274%20">Analysis of Vitamin D-Related Molecular Switches Predicts Childhood Bone Mass&lt;/a> bioquicknews&lt;/h3>
&lt;h4 id="clipped-from-news-release">Clipped from News Release&lt;/h4>
&lt;p>We are now testing whether mothers should be supplemented with vitamin D in pregnancy in a randomised controlled trial, the MAVIDOS Maternal Vitamin D Osteoporosis Study, which will report early next year.&amp;quot;&lt;/p>
&lt;h4 id="abstract-of-study">Abstract of study&lt;/h4>
&lt;p>Maternal vitamin D deficiency has been associated with reduced offspring bone mineral accrual. Retinoid-X Receptor-alpha (RXRA) is an essential cofactor in the action of 1,25(OH)2-vitamin D, and RXRA methylation in umbilical cord DNA has been associated with later offspring adiposity. We tested the hypothesis that RXRA methylation in umbilical cord DNA collected at birth is associated with offspring skeletal development, assessed by dual-energy X-ray absorptiometry, in a population-based mother-offspring cohort (Southampton Women&amp;rsquo;s Survey). Relationships between maternal plasma 25(OH)-vitamin D concentrations and cord RXRA methylation were also investigated.&lt;/p></description></item><item><title>Pancreatic Cancer association with PRKCA gene and the active form of vitamin D</title><link>/posts/pancreatic-cancer-association-with-prkca-gene-and-the-active-form-of-vitamin-d.html</link><pubDate>Sat, 10 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/pancreatic-cancer-association-with-prkca-gene-and-the-active-form-of-vitamin-d.html</guid><description>&lt;h3 id="genetic-pathways-related-to-vitamin-d-and-risk-of-pancreatic-cancer-abstract-61">Genetic pathways related to vitamin D and risk of pancreatic cancer. Abstract 61:&lt;/h3>
&lt;p>Cancer Epidemiol Biomarkers Prev November 2012 21; 61&lt;/p>
&lt;p>Hannah Arem1,&lt;/p>
&lt;p>Dennis Maeder1,&lt;/p>
&lt;p>Kai Yu1,&lt;/p>
&lt;p>Bill Wheeler2,&lt;/p>
&lt;p>Emily Steplowski2,&lt;/p>
&lt;p>Neal Freedman1,&lt;/p>
&lt;p>Susan T. Mayne3,&lt;/p>
&lt;p>Harvey Risch3,&lt;/p>
&lt;p>Joshua Sampson1, and&lt;/p>
&lt;p>Rachael Z. Stolzenberg-Solomon1&lt;/p>
&lt;p>1 National Cancer Institute, Bethesda, MD,&lt;/p>
&lt;p>2 Information Management Systems, Rockville, MD,&lt;/p>
&lt;p>3 Yale School of Public Health, New Haven, CT.&lt;/p>
&lt;p>Background: Pancreatic cancer is a rapidly fatal disease with few well-established risk factors. Genome-wide association studies (GWAS) have identified four genes associated with pancreatic cancer risk, but the low statistical significance thresholds in GWAS preclude identification of many associations and genetic risk for disease may not be fully explained by single genes or single nucleotide polymorphisms (SNPs). Collections of genes grouped into pathways may have a collective effect not detected in GWAS or candidate gene approaches. Also, biologic plausibility can be taken into consideration in pathway-based analyses. Laboratory and animal studies suggest a role for vitamin D in inhibiting tumor cell differentiation and angiogenesis, while stimulating apoptosis. Additionally, ecologic studies suggest lower pancreatic cancer incidence with higher UV exposure. However, epidemiologic studies on the association between vitamin D status and pancreatic cancer risk provide conflicting evidence with some studies suggesting positive associations. Vitamin D-related genetic pathways have not been examined in relation to pancreatic cancer risk.&lt;/p></description></item><item><title>Response to vitamin D related to DBP and CYP2RI genes</title><link>/posts/response-to-vitamin-d-related-to-dbp-and-cyp2ri-genes.html</link><pubDate>Sat, 10 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/response-to-vitamin-d-related-to-dbp-and-cyp2ri-genes.html</guid><description>&lt;h3 id="the-serum-25-hydroxyvitamin-d-response-to-vitamin-d-supplementation-is-related-to-genetic-factors-body-mass-index-and-baseline-levels">The serum 25-hydroxyvitamin D response to vitamin D supplementation is related to genetic factors, body mass index and baseline levels&lt;/h3>
&lt;p>Eur J Endocrinol August 9, 2013 EJE-13-0233&lt;/p>
&lt;p>Allan Didriksen &lt;a href="mailto:allan.didriksen@unn.no">allan.didriksen@unn.no&lt;/a>.&lt;/p>
&lt;p>Guri Grimnes,&lt;/p>
&lt;p>Moira Strand Hutchinson,&lt;/p>
&lt;p>Marie Kjærgaard,&lt;/p>
&lt;p>Johan Svartberg,&lt;/p>
&lt;p>Ragnar Martin Joakimsen and&lt;/p>
&lt;p>Rolf Jorde&lt;/p>
&lt;p>A Didriksen, Insitute of Clinical Medicine, University of Tromsø, Tromsø, Norway&lt;/p>
&lt;p>G Grimnes, Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway&lt;/p>
&lt;p>M Hutchinson, Insitute of Clinical Medicine, University of Tromsø, Tromsø, Norway&lt;/p></description></item><item><title>Might be able to predict who will benefit from vitamin D by just 2 genes</title><link>/posts/might-be-able-to-predict-who-will-benefit-from-vitamin-d-by-just-2-genes.html</link><pubDate>Sat, 03 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/might-be-able-to-predict-who-will-benefit-from-vitamin-d-by-just-2-genes.html</guid><description>&lt;h4 id="primary-vitamin-d-target-genes-allow-a-categorization-of-possible-benefits-of-vitamin-d3-supplementation">Primary Vitamin D Target Genes Allow a Categorization of Possible Benefits of Vitamin D3 Supplementation&lt;/h4>
&lt;p>PLOS ONE&lt;/p>
&lt;p>Carsten Carlberg &lt;a href="mailto:carsten.carlberg@uef.fi">carsten.carlberg@uef.fi&lt;/a>, Sabine Seuter, Vanessa D. F. de Mello, Ursula Schwab, Sari Voutilainen, Kari Pulkki, Tarja Nurmi, Jyrki Virtanen, Tomi-Pekka Tuomainen, Matti Uusitupa&lt;/p>
&lt;p>Vitamin D deficiency has been associated with an increased risk of developing a number of diseases. Here we investigated samples from 71 pre-diabetic individuals of the VitDmet study, a 5-month high dose vitamin D3 intervention trial during Finnish winter, for their changes in serum 25-hydroxyvitamin D3 (25(OH)D3) concentrations and the expression of primary vitamin D target genes in peripheral blood mononuclear cells and adipose tissue.&lt;/p></description></item><item><title>Response to Vitamin D3 varied with rs4588, D2 less response than D3 and did not change</title><link>/posts/response-to-vitamin-d3-varied-with-rs4588-d2-less-response-than-d3-and-did-not-change.html</link><pubDate>Sat, 13 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/response-to-vitamin-d3-varied-with-rs4588-d2-less-response-than-d3-and-did-not-change.html</guid><description>&lt;h3 id="changes-in-circulating-25-hydroxyvitamin-d-according-to-vitamin-d-binding-protein-genotypes-after-vitamin-d-or-d-supplementation">Changes in circulating 25-hydroxyvitamin D according to vitamin D binding protein genotypes after vitamin D₃ or D₂ supplementation.&lt;/h3>
&lt;p>Nutr J. 2013 Apr 4;12:39. &lt;a href="https://doi.org/10.1186/1475-2891-12-39.">doi: 10.1186/1475-2891-12-39.&lt;/a>&lt;/p>
&lt;p>Nimitphong H, Saetung S, Chanprasertyotin S, Chailurkit LO, Ongphiphadhanakul B.&lt;/p>
&lt;p>Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Rama 6 Rd, Rajthevi, Bangkok 10400, Thailand. &lt;a href="mailto:hataikarnn@hotmail.com">hataikarnn@hotmail.com&lt;/a>&lt;/p>
&lt;p>BACKGROUND: It is not known whether genetic variation in the vitamin D binding protein (DBP) influences 25-hydroxyvitamin D levels &lt;span>[25(OH)D]&lt;/span> after vitamin D supplementation. We aimed to investigate the changes of total 25(OH)D, 25(OH)D₃ and 25(OH)D₂ in a Thai cohort, according to type of vitamin D supplement (vitamin D₃ or D₂) and DBP genotype, after receiving vitamin D₃ or D₂ for 3 months.&lt;/p></description></item><item><title>40 percent less likely to get adequate vitamin D response if have certain genes</title><link>/posts/40-percent-less-likely-to-get-adequate-vitamin-d-response-if-have-certain-genes.html</link><pubDate>Thu, 11 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/40-percent-less-likely-to-get-adequate-vitamin-d-response-if-have-certain-genes.html</guid><description>&lt;h3 id="vitamin-d-intake-and-season-modify-the-effects-of-the-gc-and-cyp2r1-genes-on-25-hydroxyvitamin-d-concentrations">Vitamin D intake and season modify the effects of the GC and CYP2R1 genes on 25-hydroxyvitamin D concentrations.&lt;/h3>
&lt;p>J Nutr. 2013 Jan;143(1):17-26. &lt;a href="https://doi.org/10.3945/jn.112.169482.">doi: 10.3945/jn.112.169482.&lt;/a> Epub 2012 Nov 28.&lt;/p>
&lt;p>Engelman CD, Meyers KJ, Iyengar SK, Liu Z, Karki CK, Igo RP Jr, Truitt B, Robinson J, Sarto GE, Wallace R, Blodi BA, Klein ML, Tinker L, LeBlanc ES, Jackson RD, Song Y, Manson JE, Mares JA, Millen AE.&lt;/p>
&lt;p>Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. &lt;a href="mailto:cengelman@wisc.edu">cengelman@wisc.edu&lt;/a>.&lt;/p></description></item><item><title>Migration to Northern Latitudes enabled by mutation of gene: DHCR7 resulting in more vitamin D</title><link>/posts/migration-to-northern-latitudes-enabled-by-mutation-of-gene-dhcr7-resulting-in-more-vitamin-d.html</link><pubDate>Thu, 11 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/migration-to-northern-latitudes-enabled-by-mutation-of-gene-dhcr7-resulting-in-more-vitamin-d.html</guid><description>&lt;h3 id="dhcr7-mutations-linked-to-higher-vitamin-d-status-allowed-early-human-migration-to-northern-latitudes">DHCR7 Mutations linked to higher vitamin D status allowed early human migration to Northern Latitudes.&lt;/h3>
&lt;p>BMC Evol Biol. 2013 Jul 9;13(1):144.&lt;/p>
&lt;p>Kuan V, Martineau AR, Griffiths CJ, Hyppönen E, Walton R.&lt;/p>
&lt;p>BACKGROUND: Vitamin D is essential for a wide range of physiological processes including immune function and calcium homeostasis. Recent investigations have identified candidate genes which are strongly linked to concentrations of 25-hydroxyvitamin D. Since there is insufficient UVB radiation to induce year-round cutaneous synthesis of vitamin D at latitudes distant from the equator it is likely that these genes were subject to forces of natural selection. We used the fixation index (FST) to measure differences in allele frequencies in 993 individuals from ten populations to identify the presence of evolutionary selection in genes in the vitamin D pathway. We then explored the length of haplotypes in chromosomes to confirm recent positive selection.&lt;/p></description></item><item><title>Rickets: Calcium, Genes, etc</title><link>/posts/rickets-calcium-genes-etc.html</link><pubDate>Mon, 01 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/rickets-calcium-genes-etc.html</guid><description>&lt;p>
&lt;p>&lt;strong>&lt;span class="citation-abbreviation">Indian J Endocrinol Metab. &lt;/span>&lt;span class="citation-publication-date">2013 Jan-Feb; &lt;/span>&lt;span class="citation-volume">17&lt;/span>&lt;span class="citation-issue">(1)&lt;/span>&lt;span class="citation-flpages">: 1–4. &lt;/span>&lt;/strong>&lt;/p>&lt;/p>
&lt;div class="fm-citation-pmcid">
&lt;p>&lt;span class="doi">doi:  &lt;a href="http://dx.doi.org/10.4103%2F2230-8210.107789">10.4103/2230-8210.107789&lt;/a>&lt;/span>&lt;span class="fm-citation-ids-label">PMCID: &lt;/span>&lt;span>PMC3659873&lt;/span>&lt;/div>&lt;/p>
&lt;h1 class="content-title">
&lt;p>Rickets: Twists and turns in the Gordian knot&lt;/h1>&lt;/p>
&lt;div class="half_rhythm">
&lt;div class="contrib-group fm-author">
&lt;p>&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Garg%20MK%5Bauth%5D">M. K. Garg&lt;/a> and &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Kalra%20S%5Bauth%5D">Sanjay Kalra&lt;/a>&lt;sup>1&lt;/sup>&lt;/div>&lt;/p>
&lt;/div>
&lt;div class="fm-panel small half_rhythm">
&lt;div class="fm-authors-info fm-panel half_rhythm">
&lt;div class="fm-affl">
&lt;p>&lt;em>Department of Endocrinology, Command Hospital, Southern Command, Pune, Maharashtra, India&lt;/em>&lt;/div>&lt;/p>
&lt;div class="fm-affl">
&lt;p>&lt;sup>1&lt;/sup>&lt;em>Department of Endocrinology, Bharti Hospital and B.R.I.D.E., Karnal, Haryana, India&lt;/em>&lt;/div>&lt;/p>
&lt;div id="cor1">
&lt;p>&lt;strong>Corresponding Author:&lt;/strong> Col. M. K. Garg, Department of Endocrinology, Command Hospital, Southern Command, Pune, Maharashtra, India. E-mail: &lt;span class="e_id352731">&lt;a href="mailto:mkgargs@gmail.com">&lt;a href="mailto:mkgargs@gmail.com">mkgargs@gmail.com&lt;/a>&lt;/a>&lt;/span>&lt;/div>&lt;/p>
&lt;/div>
&lt;div class="fm-cpl-info fm-panel half_rhythm">
&lt;div class="fm-copyright half_rhythm">
&lt;p>&lt;a href="http://www.ncbi.nlm.nih.gov/pmc/about/copyright.html">Copyright&lt;/a> : © Indian Journal of Endocrinology and Metabolism&lt;/div>&lt;/p></description></item><item><title>Vitamin D roles in obesity: genetics and cell signaling</title><link>/posts/vitamin-d-roles-in-obesity-genetics-and-cell-signaling.html</link><pubDate>Thu, 27 Jun 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-roles-in-obesity-genetics-and-cell-signaling.html</guid><description>&lt;h4 id="the-beneficial-role-of-vitamin-d-in-obesity-possible-genetic-and-cell-signaling-mechanisms">The beneficial role of vitamin D in obesity: possible genetic and cell signaling mechanisms.&lt;/h4>
&lt;p>Nutr J. 2013 Jun 25;12(1):89.&lt;/p>
&lt;p>Vinh Qu C L Ng K, Nguy N LT.&lt;/p>
&lt;p>The prevalence rates of overweight and obesity are considered an important public issue in the United States, and both of these conditions are increasing among both children and adults. There is evidence of aberrations in the vitamin D-endocrine system in obese subjects. Vitamin D deficiency is highly prevalent in patients with obesity, and many studies have demonstrated the significant effect of calcitriol on adipocytes.&lt;/p></description></item><item><title>Rickets-vitamin D deficiency and dependency</title><link>/posts/rickets-vitamin-d-deficiency-and-dependency.html</link><pubDate>Sun, 23 Jun 2013 00:00:00 +0000</pubDate><guid>/posts/rickets-vitamin-d-deficiency-and-dependency.html</guid><description>&lt;p>Indian J Endocrinol Metab. 2012 Mar;16(2):164-76. &lt;a href="https://doi.org/10.4103/2230-8210.93732.">doi: 10.4103/2230-8210.93732.&lt;/a>&lt;/p>
&lt;p>Sahay M, Sahay R.&lt;/p>
&lt;p>Department of Nephrology, Osmania Medical College and General Hospital, Hyderabad, Andhra Pradesh, India.&lt;/p>
&lt;p>Rickets is an important problem even in countries with adequate sun exposure. The causes of rickets/osteomalacia are varied and include nutritional deficiency, especially poor dietary intake of vitamin D and calcium. Non-nutritional causes include hypophosphatemic rickets primarily due to renal phosphate losses and rickets due to renal tubular acidosis. In addition, some varieties are due to inherited defects in vitamin D metabolism and are called vitamin D dependent rickets. This chapter highlights rickets/osteomalacia related to vitamin D deficiency or to inherited defects in vitamin D metabolism. Hypophosphatemic rickets and rickets due to renal tubular acidosis are discussed in other sections of the journal.&lt;/p></description></item><item><title>Increased risk of multiple sclerosis risk in African Americans due to genes</title><link>/posts/increased-risk-of-multiple-sclerosis-risk-in-african-americans-due-to-genes.html</link><pubDate>Thu, 20 Jun 2013 00:00:00 +0000</pubDate><guid>/posts/increased-risk-of-multiple-sclerosis-risk-in-african-americans-due-to-genes.html</guid><description>&lt;h3 id="genetic-risk-variants-in-african-americans-with-multiple-sclerosis">Genetic risk variants in African Americans with multiple sclerosis&lt;/h3>
&lt;p>Neurology 10.1212/WNL.0b013e31829bfe2f&lt;/p>
&lt;p>Noriko Isobe, MD, PhD,&lt;/p>
&lt;p>Pierre-Antoine Gourraud, PhD, MPH,&lt;/p>
&lt;p>Hanne F. Harbo, MD, PhD,&lt;/p>
&lt;p>Stacy J. Caillier, BS,&lt;/p>
&lt;p>Adam Santaniello, BS,&lt;/p>
&lt;p>Pouya Khankhanian, BA,&lt;/p>
&lt;p>Martin Maiers, MS,&lt;/p>
&lt;p>Stephen Spellman, MBS,&lt;/p>
&lt;p>Nezih Cereb, MD,&lt;/p>
&lt;p>SooYoung Yang, PhD,&lt;/p>
&lt;p>Marcelo J. Pando, PhD,&lt;/p>
&lt;p>Laura Piccio, MD, PhD,&lt;/p>
&lt;p>Anne H. Cross, MD,&lt;/p>
&lt;p>Philip L. De Jager, MD, PhD,&lt;/p>
&lt;p>Bruce A.C. Cree, MD, PhD, MCR,&lt;/p></description></item><item><title>98 pcnt of genes that Vitamin D activates to reduce MS are also activated by Interferon</title><link>/posts/98-pcnt-of-genes-that-vitamin-d-activates-to-reduce-ms-are-also-activated-by-interferon.html</link><pubDate>Thu, 06 Jun 2013 00:00:00 +0000</pubDate><guid>/posts/98-pcnt-of-genes-that-vitamin-d-activates-to-reduce-ms-are-also-activated-by-interferon.html</guid><description>&lt;h4 id="25-hydroxyvitamin-d-and-ms-activity-during-therapy-with-interferon-beta-1b">25-Hydroxyvitamin D and MS Activity During Therapy with Interferon Beta-1b&lt;/h4>
&lt;p>&lt;a href="https://cmscactrims.confex.com/cmscactrims/2013/webprogram/Paper1448.html%20">CMSC Conference, May 30, 2013 &lt;/a> Florida&lt;/p>
&lt;p>Alberto Ascherio, MD , Harvard University, Boston, MA&lt;/p>
&lt;p>Kassandra Munger, ScD , Harvard University, Boston, MA&lt;/p>
&lt;p>Claire Simon, ScD , Harvard University, Boston, MA&lt;/p>
&lt;p>Ludwig Kappos, MD , University Hospital, Basel Neurology, Basel, Switzerland, Basel, Switzerland&lt;/p>
&lt;p>Chris H Polman, MD , VU Medical Center, Amsterdam, Netherlands&lt;/p>
&lt;p>Mark Freedman, MD , University of Ottawa, Ottawa, ON, Canada&lt;/p></description></item><item><title>Trying to understand the effect of genetics vitamin D levels in the blood</title><link>/posts/trying-to-understand-the-effect-of-genetics-vitamin-d-levels-in-the-blood.html</link><pubDate>Sat, 01 Jun 2013 00:00:00 +0000</pubDate><guid>/posts/trying-to-understand-the-effect-of-genetics-vitamin-d-levels-in-the-blood.html</guid><description>&lt;h2 id="exploring-the-genetic-architecture-of-circulating-25-hydroxyvitamin-d">Exploring the genetic architecture of circulating 25-hydroxyvitamin D.&lt;/h2>
&lt;p>Genet Epidemiol. 2013 Jan;37(1):92-8. &lt;a href="https://doi.org/10.1002/gepi.21694.">doi: 10.1002/gepi.21694.&lt;/a> Epub 2012 Nov 7.&lt;/p>
&lt;p>Hiraki LT, Major JM, Chen C, Cornelis MC, Hunter DJ, Rimm EB, Simon KC, Weinstein SJ, Purdue MP, Yu K, Albanes D, Kraft P.&lt;/p>
&lt;p>Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02215, USA. &lt;a href="mailto:lindahiraki@mail.harvard.edu">lindahiraki@mail.harvard.edu&lt;/a>&lt;/p>
&lt;p>The primary circulating form of vitamin D is 25-hydroxy vitamin D (25(OH)D), a modifiable trait linked with a growing number of chronic diseases. In addition to environmental determinants of 25(OH)D, including dietary sources and skin ultraviolet B (UVB) exposure, twin- and family-based studies suggest that genetics contribute substantially to vitamin D variability with heritability estimates ranging from 43% to 80%.&lt;/p></description></item><item><title>Lupus in blacks associated with low vitamin D AND short telomeres</title><link>/posts/lupus-in-blacks-associated-with-low-vitamin-d-and-short-telomeres.html</link><pubDate>Sat, 25 May 2013 00:00:00 +0000</pubDate><guid>/posts/lupus-in-blacks-associated-with-low-vitamin-d-and-short-telomeres.html</guid><description>&lt;h3 id="systemic-lupus-erythematosus-and-vitamin-d-deficiency-are-associated-with-shorter-telomere-length-among-african-americans-a-case-control-study">Systemic Lupus Erythematosus and Vitamin D Deficiency Are Associated with Shorter Telomere Length among African Americans: A Case-Control Study.&lt;/h3>
&lt;p>PLoS One. 2013 May 20;8(5):e63725. &lt;a href="https://doi.org/10.1371/journal.pone.0063725.">doi: 10.1371/journal.pone.0063725.&lt;/a> Print 2013.&lt;/p>
&lt;p>Hoffecker BM, Raffield LM, Kamen DL, Nowling TK.&lt;/p>
&lt;p>Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America.&lt;/p>
&lt;p>Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease that disproportionately affects African American females. The causes of SLE are unknown but postulated to be a combination of genetic predisposition and environmental triggers. Vitamin D deficiency is one of the possible environmental triggers. In this study we evaluated relationships between vitamin D status, cellular aging (telomere length) and anti-telomere antibodies among African American Gullah women with SLE. The study population included African American female SLE patients and unaffected controls from the Sea Island region of South Carolina. Serum 25-hydroxyvitamin D levels were measured using a nonchromatographic radioimmunoassay. Telomere length was measured in genomic DNA of peripheral blood mononuclear cells (PBMCs) by monochrome multiplex quantitative PCR. Anti-telomere antibody levels were measured by enzyme-linked immunosorbent assay (ELISA). Patients with SLE had significantly shorter telomeres and higher anti-telomere antibody titers compared to age- and gender-matched unaffected controls. There was a positive correlation between anti-telomere antibody levels and disease activity among patients and a significant correlation of shorter telomeres with lower 25-hydroxyvitamin D levels in both patients and controls. In follow-up examination of a subset of the patients, the patients who remained vitamin D deficient tended to have shorter telomeres than those patients whose 25-hydroxyvitamin D levels were repleted. Increasing 25-hydroxyvitamin D levels in African American patients with SLE may be beneficial in maintaining telomere length and preventing cellular aging. Moreover, anti-telomere antibody levels may be a promising biomarker of SLE status and disease activity.&lt;/p></description></item><item><title>Macular degeneration 4X more likely if low vitamin D and a particular gene</title><link>/posts/macular-degeneration-4x-more-likely-if-low-vitamin-d-and-a-particular-gene.html</link><pubDate>Sun, 12 May 2013 00:00:00 +0000</pubDate><guid>/posts/macular-degeneration-4x-more-likely-if-low-vitamin-d-and-a-particular-gene.html</guid><description>&lt;h4 id="genetics-factor-in-vitamin-d-amd-link">Genetics factor in vitamin D, AMD link&lt;/h4>
&lt;p>&lt;strong>&lt;a href="http://ophthalmologytimes.modernmedicine.com/node/369696%20">Ophthalmology Times Staff Reports&lt;/a> MAY 05, 2013&lt;/strong>&lt;/p>
&lt;p>Seattle—Adequate levels of vitamin D can decrease the risk of age-related macular degeneration (AMD), but most markedly in individuals with two risk alleles for the CFH Y402H genotype, said Amy Millen, PhD.&lt;/p>
&lt;p>Specifically, the association between serum &lt;span>[25(OH)D]&lt;/span> and AMD is modified by the presence of the CFH Y402H polymorphism.&lt;/p>
&lt;p>“Previous studies have shown a relationship between vitamin D and AMD,” said Dr. Millen, assistant professor, Department of Social and Preventive Medicine at the University at Buffalo, New York. “We looked to see if it was modified by the genetic risk of AMD.”&lt;/p></description></item><item><title>Obese have 50 percent less of two enzymes in fatty tissue to process vitamin D</title><link>/posts/obese-have-50-percent-less-of-two-enzymes-in-fatty-tissue-to-process-vitamin-d.html</link><pubDate>Sun, 12 May 2013 00:00:00 +0000</pubDate><guid>/posts/obese-have-50-percent-less-of-two-enzymes-in-fatty-tissue-to-process-vitamin-d.html</guid><description>&lt;h4 id="expression-of-vitamin-d-metabolizing-enzymes-in-human-adipose-tissue-the-effect-of-obesity-and-diet-induced-weight-loss">Expression of vitamin D-metabolizing enzymes in human adipose tissue-the effect of obesity and diet-induced weight loss.&lt;/h4>
&lt;p>Int J Obes (Lond). 2013 May;37(5):651-7. &lt;a href="https://doi.org/10.1038/ijo.2012.112.">doi: 10.1038/ijo.2012.112.&lt;/a> Epub 2012 Jul 17.&lt;/p>
&lt;p>Wamberg L, Christiansen T, Paulsen SK, Fisker S, Rask P, Rejnmark L, Richelsen B, Pedersen SB.&lt;/p>
&lt;p>Department of Endocrinology and Internal Medicine MEA, Aarhus University Hospital, Aarhus, Denmark.&lt;/p>
&lt;p>Objective: Low vitamin D (VD) levels are common in obesity. We hypothesized that this may be due to metabolism of VD in &lt;strong>adipose tissue&lt;/strong> (AT). Thus, we studied (1) whether the VD-metabolizing enzymes were expressed differently in AT of lean and obese individuals and in visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT), and (2) whether their expression was influenced by weight loss.&lt;/p></description></item><item><title>Poorly functioning Vitamin D Receptor (VDR) was 5X more likely in children with low vitamin D levels</title><link>/posts/poorly-functioning-vitamin-d-receptor-vdr-was-5x-more-likely-in-children-with-low-vitamin-d-levels.html</link><pubDate>Sun, 12 May 2013 00:00:00 +0000</pubDate><guid>/posts/poorly-functioning-vitamin-d-receptor-vdr-was-5x-more-likely-in-children-with-low-vitamin-d-levels.html</guid><description>&lt;h3 id="association-of-vitamin-d-related-gene-polymorphisms-with-manifestation-of-vitamin-d-deficiency-in-children">Association of vitamin D-related gene polymorphisms with manifestation of vitamin D deficiency in children.&lt;/h3>
&lt;p>Endocr J. 2012;59(11):1007-14. Epub 2012 Jul 8.&lt;/p>
&lt;p>Kitanaka S, Isojima T, Takaki M, Numakura C, Hayasaka K, Igarashi T.&lt;/p>
&lt;p>Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan. &lt;a href="mailto:sachi-tky@umin.ac.jp">sachi-tky@umin.ac.jp&lt;/a>&lt;/p>
&lt;p>The prevalence of vitamin D deficiency, presenting as hypocalcemic seizures or rickets in children, is increasing worldwide due to insufficient vitamin D intake and lack of exposure to sunshine. However, considering that relatively few children with low 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span> levels manifest symptoms, it is possible that genetic factors may predispose individuals to vitamin D deficiency. Recent twin studies have reported that the level of serum of 25(OH)D is influenced by genetic factors. In addition, genome-wide association studies and candidate gene studies have revealed that several vitamin D-related genes, including VDR, GC, NADSYN1, CYP2R1, CYP24A1, CYP27B1, and C10orf88 contribute to variations in serum 25(OH)D levels. To investigate whether genetic predisposition contributes to vitamin D deficiency, we analyzed polymorphisms in vitamin D-related genes in 30 Japanese patients with vitamin D deficiency presenting at less than 4 years of age, along with 66 controls. A χ(2) test showed that the genotype frequencies of BsmI polymorphism in VDR and rs10898191 in NADSYN1 were significantly different between the two groups. The allele frequencies of BsmI, ApaI, TaqI in VDR, rs10898191 in NADSYN1, and rs705117 in GC were also significantly different. In particular, the frequency of the BAtS haplotype in VDR was significantly increased in the patient group relative to controls (p = 0.0014; odds ratio, &lt;strong>5.61&lt;/strong> ; 95% confidence interval 1.92 - 16.40). Although this is a small study, our findings suggest that VDR, NADSYN1, and GC polymorphisms may be linked to the manifestation of vitamin D deficiency in Japanese children.&lt;/p></description></item><item><title>Low frequency hearing loss (Otosclerosis) associated with vitamin D genes</title><link>/posts/low-frequency-hearing-loss-otosclerosis-associated-with-vitamin-d-genes.html</link><pubDate>Sat, 04 May 2013 00:00:00 +0000</pubDate><guid>/posts/low-frequency-hearing-loss-otosclerosis-associated-with-vitamin-d-genes.html</guid><description>&lt;h4 id="otosclerosis-and-vitamin-d-receptor-gene-polymorphism">Otosclerosis and vitamin D receptor gene polymorphism&lt;/h4>
&lt;p>American Journal of Otolaryngology. Available online 29 April 2013&lt;/p>
&lt;p>Yavuz Selim Yıldırım, MDa, b, &lt;a href="mailto:dryavuzselim@yahoo.com">dryavuzselim@yahoo.com&lt;/a>&lt;/p>
&lt;p>Tayfun Apuhan, MD c,&lt;/p>
&lt;p>Selma Düzenli, MD d,&lt;/p>
&lt;p>Ali Osman Arslan, MD d&lt;/p>
&lt;p>a Department of Otorhinolaryngology and Head and Neck Surgery, Bezmialem Vakif University, Faculty of Medicine, Istanbul&lt;/p>
&lt;p>b Department of Otorhinolaryngology and Head and Neck Surgery, Haseki Training and Research Hospital, Istanbul&lt;/p>
&lt;p>c Department of Ear Nose Throat Clinics, Abant Izzet Baysal University, Medical Faculty, Bolu, Turkey&lt;/p></description></item><item><title>Genes in white blood cells of blacks associated with vitamin D deficiency</title><link>/posts/genes-in-white-blood-cells-of-blacks-associated-with-vitamin-d-deficiency.html</link><pubDate>Wed, 24 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/genes-in-white-blood-cells-of-blacks-associated-with-vitamin-d-deficiency.html</guid><description>&lt;h2 id="a-genome-wide-methylation-study-of-severe-vitamin-d-deficiency-in-african-american-adolescents">A Genome-Wide Methylation Study of Severe Vitamin D Deficiency in African American Adolescents&lt;/h2>
&lt;p>The Journal of Pediatrics. Volume 162, Issue 5 , Pages 1004-1009.e1, May 2013&lt;/p>
&lt;p>Haidong Zhu, MD, PhD email address , Xiaoling Wang, MD, PhD , Huidong Shi, PhD ,&lt;/p>
&lt;p>Shaoyong Su, PhD , Gregory A. Harshfield, PhD , Bernard Gutin, PhD , Harold Snieder, PhD , Yanbin Dong, MD, PhD&lt;/p>
&lt;p>Received 2 July 2012; received in revised form 13 September 2012; accepted 31 October 2012. published online 10 December 2012.&lt;/p></description></item><item><title>Melanoma reduces by half the amount of vitamin D activated by the skin</title><link>/posts/melanoma-reduces-by-half-the-amount-of-vitamin-d-activated-by-the-skin.html</link><pubDate>Wed, 17 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/melanoma-reduces-by-half-the-amount-of-vitamin-d-activated-by-the-skin.html</guid><description>&lt;h3 id="expression-of-the-vitamin-d-activating-enzyme-1α-hydroxylase-cyp27b1-decreases-during-melanoma-progression">Expression of the vitamin D-activating enzyme 1α-hydroxylase (CYP27B1) decreases during melanoma progression.&lt;/h3>
&lt;p>Hum Pathol. 2013 Mar;44(3):374-87. &lt;a href="https://doi.org/10.1016/j.humpath.2012.03.031.">doi: 10.1016/j.humpath.2012.03.031.&lt;/a> Epub 2012 Sep 17.&lt;/p>
&lt;p>Brożyna AA, Jóźwicki W, Janjetovic Z, Slominski AT &lt;a href="mailto:aslominski@uthsc.edu">aslominski@uthsc.edu&lt;/a>&lt;/p>
&lt;p>Department of Tumor Pathology and Pathomorphology, Oncology Centre-Prof. Franciszek Łukaszczyk Memorial Hospital, The Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University, 85-796 Bydgoszcz, Poland.&lt;/p>
&lt;p>1α-Hydroxylase (CYP27B1), the enzyme responsible for the synthesis of the biologically active form of vitamin D (1,25(OH)(2)D(3)), is expressed in the skin. To assess the correlation between progression of melanocytic tumors and CYP27B1, we analyzed its expression in 29 benign nevi, 75 primary cutaneous melanomas, 40 metastases, and 4 re-excision and 6 normal skin biopsies. Immunoreactivity for CYP27B1 was significantly lower in the vertical growth phase and metastatic melanomas (0.6 and 0.5 arbitrary units, respectively) in comparison with nevi and radial growth phase tumors (1.2 and 1.1 arbitrary units, respectively); and expression was reduced in more advanced lesions (Clark levels III-V, Breslow thickness ≥2.1 mm; 0.8 and 0.7 arbitrary units, respectively). There was an inverse correlation between CYP27B1 and Ki-67 expression. Furthermore, CYP27B1 expression was reduced in primary melanomas that created metastases in comparison with non-metastasizing melanomas. Reduced CYP27B1 expression in radial growth phase was related to shorter overall survival (810 versus 982 versus 1151 days in melanomas with absent, low, and high CYP27B1 immunoreactivity), and low CYP27B1 expression in radial growth phase and vertical growth phase was related to shorter disease-free survival (114 versus 339 versus 737 days and 129 versus 307 versus 737 days, respectively, in melanomas with absent, low, and high CYP27B1). Also, CYP27B1 expression was inversely related to melanin in melanoma cells in vivo and melanoma cells cultured in vitro. Thus, reduction of CYP27B1 correlates with melanoma phenotype and behavior, and its lack affects the survival of melanoma patients, indicating a role in the pathogenesis and progression of this cancer.&lt;/p></description></item><item><title>Common Vitamin D gene variants and resulting diseases</title><link>/posts/common-vitamin-d-gene-variants-and-resulting-diseases.html</link><pubDate>Sat, 13 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/common-vitamin-d-gene-variants-and-resulting-diseases.html</guid><description>&lt;p>&lt;strong>Abstract&lt;/strong>&lt;/p>
&lt;p>The vitamin D binding protein (DBP) is the major plasma carrier for vitamin D and its metabolites, but it is also an actin scavenger, and is the precursor to the immunomodulatory protein, Gc-MAF. Two missense variants of the DBP gene - rs7041 encoding Asp432Glu and rs4588 encoding Thr436Lys - change the amino acid sequence and alter the protein function.&lt;/p>
&lt;p>They are common enough to generate population-wide constitutive differences in vitamin D status, based on assay of the serum metabolite, 25-hydroxyvitamin D (25OHD).&lt;/p></description></item><item><title>Vitamin D - Health panacea or false prophet (Klotho gene)</title><link>/posts/vitamin-d-health-panacea-or-false-prophet-klotho-gene.html</link><pubDate>Sat, 13 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-health-panacea-or-false-prophet-klotho-gene.html</guid><description>&lt;h2 id="vitamin-d-health-panacea-or-false-prophet">Vitamin D: Health panacea or false prophet?&lt;/h2>
&lt;p>Nutrition 29 (2013) 37-41, Article history: Received 27 March 2012 Accepted 11 May 2012&lt;/p>
&lt;p>Michael J. Glade h.D., F.A.C.N., C.N.S. &lt;a href="mailto:the_nutrition_doctor@yahoo.com">the_nutrition_doctor@yahoo.com&lt;/a>.&lt;/p>
&lt;p>The Nutrition Doctor, Skokie, Illinois, USA&lt;/p>
&lt;p>Vitamin D deficiency, diagnosed when the serum 25-hydroxyvitamin D (25-OHD3) concentration is less than 20 ng/mL, has joined vitamin A deficiency as two of the most common nutrition-responsive medical conditions worldwide. &lt;strong>There have been more scientific articles published about vitamin D in the 21st century than about any other vitamin&lt;/strong> , reflecting the massive expansion of the field of vitamin D research. Adequate vitamin D status has been linked to decreased risks of developing&lt;/p></description></item><item><title>Genes and different vitamin D related substances in the skin</title><link>/posts/genes-and-different-vitamin-d-related-substances-in-the-skin.html</link><pubDate>Mon, 08 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/genes-and-different-vitamin-d-related-substances-in-the-skin.html</guid><description>&lt;h1 id="novel-vitamin-d-photoproducts-and-their-precursors-in-the-skin">Novel vitamin D photoproducts and their precursors in the skin&lt;/h1>
&lt;p>Dermato Endencronology Volume 5, Issue 1 January/February/March 2013&lt;/p>
&lt;p>&lt;a href="http://dx.doi.org/10.4161/derm.23938">http://dx.doi.org/10.4161/derm.23938&lt;/a>&lt;/p>
&lt;p>Keywords: 5,7-dienes, dermal fibroblasts, keratinocytes, melanocytes, melanoma cells, skin, vitamin D&lt;/p>
&lt;p>Authors: Andrzej T. Slominski, Tae-Kang Kim, Michal A. Zmijewski, Zorica Janjetovic, Wei Li, Jianjun Chen, Ekaterina I. Kusniatsova, Igor Semak, Arnold Postlethwaite, Duane D. Miller, Jordan K. Zjawiony and Robert C. Tuckey&lt;/p>
&lt;p>Novel metabolic pathways initiated by the enzymatic action of CYP11A1 on 7DHC (7-dehydrocholesterol), ergosterol, vitamins D3 and D2 were characterized with help of chemical synthesis, UV and mass spectrometry and NMR analyses.&lt;/p></description></item><item><title>291 genes improved expression by 2000 IU of vitamin D – RCT</title><link>/posts/291-genes-improved-expression-by-2000-iu-of-vitamin-d-rct.html</link><pubDate>Thu, 21 Mar 2013 00:00:00 +0000</pubDate><guid>/posts/291-genes-improved-expression-by-2000-iu-of-vitamin-d-rct.html</guid><description>&lt;h4 id="influence-of-vitamin-d-status-and-vitamin-d3-supplementation-on-genome-wide-expression-of-white-blood-cells-a-randomized-double-blind-clinical-trial">Influence of Vitamin D Status and Vitamin D3 Supplementation on Genome Wide Expression of White Blood Cells: A Randomized Double-Blind Clinical Trial&lt;/h4>
&lt;p>PLoS ONE 8(3): e58725. doi:10.1371/journal.pone.0058725&lt;/p>
&lt;p>Arash Hossein-nezhad, Avrum Spira, Michael F. Holick&lt;/p>
&lt;p>Background: Although there have been numerous observations of vitamin D deficiency and its links to chronic diseases, no studies have reported on how vitamin D status and vitamin D3 supplementation affects broad gene expression in humans. The objective of this study was to determine the effect of vitamin D status and subsequent vitamin D supplementation on broad gene expression in healthy adults. (Trial registration: ClinicalTrials.gov NCT01696409).&lt;/p></description></item><item><title>Vitamin D receptor gene associated with 50 percent more type 2 Diabetes – meta-analyses 2013, 2016</title><link>/posts/vitamin-d-receptor-gene-associated-with-50-percent-more-type-2-diabetes-meta-analyses-2013-2016.html</link><pubDate>Wed, 20 Mar 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-receptor-gene-associated-with-50-percent-more-type-2-diabetes-meta-analyses-2013-2016.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#type-2-diabetes-in-chinese-is-50-percent-more-likely-if-have-vitamin-d-receptor-gene-problem--meta-analysis-2016">Type 2 Diabetes in Chinese is 50 percent more likely if have Vitamin D Receptor gene problem – meta-analysis 2016&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-receptor-gene-polymorphisms-and-type-2-diabetes-a-meta-analysis--march-2013">Vitamin D Receptor Gene Polymorphisms and Type 2 Diabetes: A Meta-analysis.- March 2013&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="type-2-diabetes-in-chinese-is-50-percent-more-likely-if-have-vitamin-d-receptor-gene-problem--meta-analysis-2016">Type 2 Diabetes in Chinese is 50 percent more likely if have Vitamin D Receptor gene problem – meta-analysis 2016&lt;/h4>
&lt;p>&lt;strong>The genetic polymorphisms in vitamin D receptor and the risk of type 2 diabetes mellitus: an updated meta-analysis.&lt;/strong>&lt;/p></description></item><item><title>No apparent genetic association between vitamin D and obesity</title><link>/posts/no-apparent-genetic-association-between-vitamin-d-and-obesity.html</link><pubDate>Tue, 12 Mar 2013 00:00:00 +0000</pubDate><guid>/posts/no-apparent-genetic-association-between-vitamin-d-and-obesity.html</guid><description>&lt;h3 id="genetic-association-analysis-of-vitamin-d-pathway-with-obesity-traits">Genetic association analysis of vitamin D pathway with obesity traits.&lt;/h3>
&lt;p>Int J Obes (Lond). 2013 Feb 5. &lt;a href="https://doi.org/10.1038/ijo.2013.6.">doi: 10.1038/ijo.2013.6.&lt;/a>&lt;/p>
&lt;p>Vimaleswaran KS, Cavadino A, Berry DJ; The Genetic Investigation of Anthropometric Traits (GIANT) Consortium, Whittaker JC, Power C, Järvelin MR, Hyppönen E.&lt;/p>
&lt;p>Centre for Paediatric Epidemiology and Biostatistics, MRC Centre of Epidemiology for Child Health, UCL Institute of Child Health, London, UK.&lt;/p>
&lt;p>Objective:Observational studies have examined the link between vitamin D deficiency and obesity traits. Some studies have reported associations between vitamin D pathway genes such as VDR, GC and CYP27B1 with body mass index (BMI) and waist circumference (WC); however, the findings have been inconsistent. Therefore, we investigated the involvement of vitamin D metabolic pathway genes in obesity-related traits in a large population-based study.&lt;/p></description></item><item><title>Vitamin D gene expression associated with diseases</title><link>/posts/vitamin-d-gene-expression-associated-with-diseases.html</link><pubDate>Tue, 12 Mar 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-gene-expression-associated-with-diseases.html</guid><description>&lt;h2 id="plasma-25-hydroxyvitamin-d-level-and-blood-gene-expression-profiles-a-cross-sectional-study-of-the-norwegian-women-and-cancer-post-genome-cohort">Plasma 25 hydroxyvitamin D level and blood gene expression profiles: a cross-sectional study of the Norwegian Women and Cancer Post-genome Cohort.&lt;/h2>
&lt;p>Eur J Clin Nutr. 2013 Mar 6. &lt;a href="https://doi.org/10.1038/ejcn.2013.53.">doi: 10.1038/ejcn.2013.53.&lt;/a>&lt;/p>
&lt;p>Standahl Olsen K, Rylander C, Brustad M, Aksnes L, Lund E.&lt;/p>
&lt;p>Department of Community Medicine, University of Tromsø, Tromsø, Norway.&lt;/p>
&lt;p>Background/Objectives:Vitamin D deficiency has been associated with increased risk of developing several diseases, but much is unknown about the molecular effects involved. Gene expression technology is increasingly being used to elucidate molecular mechanisms related to nutritional factors, and in this study of free-living, middle-aged Norwegian women, we aimed at identifying gene expression pathways in the blood associated with vitamin D status.&lt;/p></description></item><item><title>Vitamin D level can be high, but little benefit: due to kidney, genes, low Magnesium etc.</title><link>/posts/vitamin-d-level-can-be-high-but-little-benefit-due-to-kidney-genes-low-magnesium-etc.html</link><pubDate>Sun, 10 Mar 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-level-can-be-high-but-little-benefit-due-to-kidney-genes-low-magnesium-etc.html</guid><description/></item><item><title>Genes indicate that Obesity causes vitamin D deficiency</title><link>/posts/genes-indicate-that-obesity-causes-vitamin-d-deficiency.html</link><pubDate>Tue, 12 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/genes-indicate-that-obesity-causes-vitamin-d-deficiency.html</guid><description>&lt;h4 id="causal-relationship-between-obesity-and-vitamin-d-status-bi-directional-mendelian-randomization-analysis-of-multiple-cohorts">Causal Relationship between Obesity and Vitamin D Status: Bi-Directional Mendelian Randomization Analysis of Multiple Cohorts&lt;/h4>
&lt;p>PLOS One&lt;/p>
&lt;p>Karani S. Vimaleswaran equal contributor, Diane J. Berry equal contributor, Chen Lu,&lt;/p>
&lt;p>Emmi Tikkanen, Stefan Pilz, Linda T. Hiraki, Jason D. Cooper, Zari Dastani,&lt;/p>
&lt;p>Rui Li, Denise K. Houston, Andrew R. Wood, Karl Michaëlsson, Liesbeth Vandenput, Elina Hyppönen equal contributor mail&lt;/p>
&lt;h4 id="background">Background&lt;/h4>
&lt;p>Obesity is associated with vitamin D deficiency, and both are areas of active public health concern. We explored the causality and direction of the relationship between body mass index (BMI) and 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span> using genetic markers as instrumental variables (IVs) in bi-directional Mendelian randomization (MR) analysis.&lt;/p></description></item><item><title>Mutations in CYP24A1 gene (vitamin D) associated with kidney problems</title><link>/posts/mutations-in-cyp24a1-gene-vitamin-d-associated-with-kidney-problems.html</link><pubDate>Mon, 21 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/mutations-in-cyp24a1-gene-vitamin-d-associated-with-kidney-problems.html</guid><description>&lt;h4 id="125-oh2d-24-hydroxylase-cyp24a1-deficiency-as-a-cause-of-nephrolithiasis">1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of Nephrolithiasis.&lt;/h4>
&lt;p>Clin J Am Soc Nephrol. 2013 Jan 4.&lt;/p>
&lt;p>Nesterova G, Malicdan MC, Yasuda K, Sakaki T, Vilboux T, Ciccone C, Horst R, Huang Y, Golas G, Introne W, Huizing M, Adams D, Boerkoel CF, Collins MT, Gahl WA.&lt;/p>
&lt;p>Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland;,&lt;/p>
&lt;p>†Department of Biotechnology, Faculty of Engineering, Toyama Prefectural University, Toyama, Japan;,&lt;/p></description></item><item><title>GC, CYP2R1 and DHCR7 genes associated with low vitamin D levels in China – 2012, 2013</title><link>/posts/gc-cyp2r1-and-dhcr7-genes-associated-with-low-vitamin-d-levels-in-china-2012-2013.html</link><pubDate>Sun, 20 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/gc-cyp2r1-and-dhcr7-genes-associated-with-low-vitamin-d-levels-in-china-2012-2013.html</guid><description>&lt;h3 id="span-stylecolorf00two-articles-from-china-on-this-page-have-the-same-conclusionspan">&lt;span style="color:#F00;">Two articles from China on this page have the same conclusion&lt;/span>&lt;/h3>
&lt;hr>
&lt;h3 id="the-gc-cyp2r1-and-dhcr7-genes-are-associated-with-vitamin-d-levels-in-northeastern-han-chinese-children">The GC, CYP2R1 and DHCR7 genes are associated with vitamin D levels in northeastern Han Chinese children.&lt;/h3>
&lt;p>Swiss Med Wkly. &lt;strong>2012 July&lt;/strong> 16;142:w13636. &lt;a href="https://doi.org/10.4414/smw.2012.13636.">doi: 10.4414/smw.2012.13636.&lt;/a>&lt;/p>
&lt;p>Zhang Y, Wang X, Liu Y, Qu H, Qu S, Wang W, Ren L.&lt;/p>
&lt;p>Department of Pediatrics, Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, PR China. &lt;a href="mailto:zhangyuling0000@yahoo.com.cn">zhangyuling0000@yahoo.com.cn&lt;/a>&lt;/p>
&lt;p>Vitamin D deficiency is associated with risk in several diseases. Vitamin D status has high heritability, yet the genetic epidemiology of vitamin D or its metabolites has not been well studied. Our objective was to identify the relationship among three vitamin D-related genes (GC, CYP2R1 and DHCR7/NADSYN1) and the levels of 25(OH)D in northeastern Han Chinese children. A total of 506 northeastern Han Chinese children were enrolled in this study. Linear regression was used to examine the impact of 12 SNPs on 25(OH)D concentrations after adjustment for age, gender, BMI and regular usage of vitamin D, and Bonferroni&amp;rsquo;s method was adopted for multiple corrections. The two SNPs in GC (rs222020, rs2298849), four SNPs in CYP2R1 (rs10741657, rs10766197, rs12794714 and rs1562902) and two SNPs in DHCR7/NADSYN1 (rs3829251, rs12785878) were significantly associated with plasma 25(OH)D concentrations under both additive and recessive models (P &amp;lt;0.05). The genotypes of the CYP2R1 rs2060793 polymorphism showed positive association with serum 25(OH)D status under all of the three genetic models even after correction for multiple comparison. This population-based study was the first to confirm the strong effects of the GC, CYP2R1 and DHCR7/NADSYN1 loci on circulating 25(OH)D concentrations in northeastern Han Chinese children.&lt;/p></description></item><item><title>The Anti-cancer Actions of Vitamin D</title><link>/posts/the-anti-cancer-actions-of-vitamin-d.html</link><pubDate>Wed, 05 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/the-anti-cancer-actions-of-vitamin-d.html</guid><description>&lt;p>Anti-Cancer Agents in Medicinal Chemistry Volume 13 Issue 1 pp.126-139 (14)&lt;/p>
&lt;p>Authors: Kun-Chun Chiang, Tai C. Chen&lt;/p>
&lt;p>Vitamin D3 is biologically inert. To become active, it requires two successive hydroxylation steps catalyzed by two cytochrome P450 enzymes, first to synthesize the pro-hormone 25-hydroxyvitamin D3 &lt;span>[25(OH)D3]&lt;/span> and then the active hormone 1α,25- dihydroxyvitamin D3 &lt;span>[1α,25(OH)2D3]&lt;/span>. 1α,25(OH)2D3 has high affinity for the vitamin D receptor (VDR), a transcription factor and a member of the steroid receptor superfamily. Through VDR, 1α,25(OH)2D3 regulates more than 200 genes in mammals, including those involved in the calcium and phosphorus homeostasis, immune function, reproduction, cardiovascular, central nerve system, inflammation, angiogenesis, and cellular proliferation, differentiation and apoptosis. Due to its versatile roles in maintaining and regulating normal cellular phenotypes and functions, 1α,25(OH)2D3 has been implicated as an anti-cancer agent. In fact, ecological and epidemiologic data have linked vitamin D deficiency with the incidence and mortality of many types of cancer. More importantly, in vitro and in vivo animal model studies have clearly demonstrated the anti-tumor effects of vitamin D. In this review, we describe the anticancer actions of vitamin D, with special emphasis on different pathways underlying the VDR-mediated genomic as well as less-defined non-genomic actions of vitamin D.&lt;/p></description></item><item><title>Vitamin D Receptor genes bb and BB and Osteoporosis, esp. for blacks – meta-analysis</title><link>/posts/vitamin-d-receptor-genes-bb-and-bb-and-osteoporosis-esp-for-blacks-meta-analysis.html</link><pubDate>Fri, 30 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-receptor-genes-bb-and-bb-and-osteoporosis-esp-for-blacks-meta-analysis.html</guid><description>&lt;h4 id="vitamin-d-receptor-bsmi-polymorphism-and-osteoporosis-risk-a-meta-analysis-from-26-studies">Vitamin D Receptor BsmI Polymorphism and Osteoporosis Risk: A Meta-Analysis from 26 Studies&lt;/h4>
&lt;p>Genetic Testing and Molecular Biomarkers – Nov 2012&lt;/p>
&lt;p>Rui-Fen Sun,2,* Qun-Hui Li,1 Da-Xing Wang,1 Feng Zhao,1 Jun-Min Li,1 Qi Pu,1 Zhong-Zi Zhang,1 Yan Jin,1 Bai-Lian Liu,1 and Ying Xiong1&lt;/p>
&lt;p>1 Department of Orthopedics, Kunming Medical University, National Clinical Key Specialty, Yanan Hospital, Kunming, People&amp;rsquo;s Republic of China.&lt;/p>
&lt;p>2 Central Laboratory, Yunnan University of Chinese Traditional Medicine, Kunming, People&amp;rsquo;s Republic of China.&lt;/p></description></item><item><title>GC and CYP2R1 genes associated with higher summer vitamin D levels</title><link>/posts/gc-and-cyp2r1-genes-associated-with-higher-summer-vitamin-d-levels.html</link><pubDate>Thu, 29 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/gc-and-cyp2r1-genes-associated-with-higher-summer-vitamin-d-levels.html</guid><description>&lt;h4 id="vitamin-d-intake-and-season-modify-the-effects-of-the-gc-and-cyp2r1-genes-on-25-hydroxyvitamin-d-concentrations123">Vitamin D Intake and Season Modify the Effects of the GC and CYP2R1 Genes on 25-Hydroxyvitamin D Concentrations1,2,3&lt;/h4>
&lt;p>J. Nutr. January 1, 2013 jn.112.169482&lt;/p>
&lt;p>Corinne D. Engelman4, &lt;a href="mailto:cengelman@wisc.edu">cengelman@wisc.edu&lt;/a>, Kristin J. Meyers5, Sudha K. Iyengar7, Zhe Liu5, Chitra K. Karki5, Robert P. Igo Jr7, Barbara Truitt7, Jennifer Robinson8,9, Gloria E. Sarto6, Robert Wallace9, Barbara A. Blodi5, Michael L. Klein10, Lesley Tinker11, Erin S. LeBlanc12, Rebecca D. Jackson13, Yiqing Song14, JoAnn E. Manson14,15, Julie A. Mares5, and Amy E. Millen16&lt;/p></description></item><item><title>How Vitamin D prevents many cancers (c-MYC)</title><link>/posts/how-vitamin-d-prevents-many-cancers-c-myc.html</link><pubDate>Sun, 25 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/how-vitamin-d-prevents-many-cancers-c-myc.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-receptor-as-a-master-regulator-of-the-c-mycmxd1-network">Vitamin D receptor as a master regulator of the c-MYC/MXD1 network&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-web">See also web&lt;/a>&lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h2 id="vitamin-d-receptor-as-a-master-regulator-of-the-c-mycmxd1-network">Vitamin D receptor as a master regulator of the c-MYC/MXD1 network&lt;/h2>
&lt;p>PNAS November 13, 2012 vol. 109 no. 46 18827-18832&lt;/p>
&lt;p>Reyhaneh Salehi-Tabara, Loan Nguyen-Yamamotoa, Luz E. Tavera-Mendozaa, Thomas Quailb, Vassil Dimitrovb, Beum-Soo Anb,c, Leon Glassb, David Goltzmana,b, and John H. Whitea,b, &lt;a href="mailto:john.white@mcgill.ca">john.white@mcgill.ca&lt;/a>&lt;/p>
&lt;p>A Departments of Medicine and&lt;/p>
&lt;p>B Physiology, McGill University, Montreal, QC, Canada H3G 1Y6; and&lt;/p></description></item><item><title>Transgeneration vitamin D deficiency related to MS was found in mice</title><link>/posts/transgeneration-vitamin-d-deficiency-related-to-ms-was-found-in-mice.html</link><pubDate>Sun, 25 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/transgeneration-vitamin-d-deficiency-related-to-ms-was-found-in-mice.html</guid><description>&lt;h4 id="prenatal-vitamin-d-deficiency-induces-an-early-and-more-severe-experimental-autoimmune-encephalomyelitis-in-the-second-generation">Prenatal Vitamin D Deficiency Induces an Early and More Severe Experimental Autoimmune Encephalomyelitis in the Second Generation&lt;/h4>
&lt;p>Int. J. Mol. Sci. 2012, 13(9), 10911-10919; doi:10.3390/ijms130910911&lt;/p>
&lt;p>Diana Andrea Fernandes de Abreu 1 , Véréna Landel 1 , Adrian G. Barnett 2 , John McGrath 3,4 , Darryl Eyles 3,4 and Francois Feron 1,*&lt;/p>
&lt;p>1 Neurobiology of Cell Interactions and Neurophysiopathology, Centre National de la Recherche Scientifique, UMR 7259, Aix Marseille Université, Marseille 13015, France&lt;/p></description></item><item><title>Epigenetics, vitamin D, and Multiple Sclerosis</title><link>/posts/epigenetics-vitamin-d-and-multiple-sclerosis.html</link><pubDate>Wed, 21 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/epigenetics-vitamin-d-and-multiple-sclerosis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#epigenetic-changes-in-patients-with-multiple-sclerosis---nov-2012">Epigenetic changes in patients with multiple sclerosis - Nov 2012&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#epigenetics---is-it-real-new-york-times-review-of-plos-genetics-article---july-2016">Epigenetics - is it real: New York Times review of PLOS Genetics article - July 2016&lt;/a>&lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h2 id="epigenetic-changes-in-patients-with-multiple-sclerosis---nov-2012">Epigenetic changes in patients with multiple sclerosis - Nov 2012&lt;/h2>
&lt;p>Nat Rev Neurol. 2012 Nov 20. &lt;a href="https://doi.org/10.1038/nrneurol.2012.226.">doi: 10.1038/nrneurol.2012.226.&lt;/a>&lt;/p>
&lt;p>Koch MW, Metz LM, Kovalchuk O.&lt;/p>
&lt;p>Department of Clinical Neurosciences, University of Calgary, Foothills Hospital, 1403-29th Street N. W., Calgary, AB T2N 2T9, Canada.&lt;/p>
&lt;p>Epigenetic changes influence gene expression without altering the DNA sequence. DNA methylation, histone modification and microRNA-associated post-transcriptional gene silencing are three key epigenetic mechanisms. Multiple sclerosis (MS) is a disease of the CNS with both inflammatory and neurodegenerative features. Although studies on epigenetic changes in MS only began in the past decade, a growing body of literature suggests that epigenetic changes may be involved in the development of MS, possibly by mediating the effects of environmental risk factors, such as&lt;/p></description></item><item><title>Difference in Fok gene reduced response to vitamin D by 35 percent</title><link>/posts/difference-in-fok-gene-reduced-response-to-vitamin-d-by-35-percent.html</link><pubDate>Sat, 17 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/difference-in-fok-gene-reduced-response-to-vitamin-d-by-35-percent.html</guid><description>&lt;h1 id="vitamin-d-receptor-fok-i-polymorphism-modulates-diabetic-host-response-to-vitamin-d-intake">Vitamin D Receptor Fok-I Polymorphism Modulates Diabetic Host Response to Vitamin D Intake&lt;/h1>
&lt;p>Need for a nutrigenetic approach&lt;/p>
&lt;p>Diabetes Care November 16, 2012&lt;/p>
&lt;p>Tirang R. Neyestani, PHD1⇓, Abolghassem Djazayery, PHD2, Sakineh Shab-Bidar, MSC2, Mohammad Reza Eshraghian, PHD3, Ali Kalayi, BSC1, Nastaran Shariátzadeh, BSC1, Niloufar Khalaji, MSC1, Malihe Zahedirad, MSC1, A’zam Gharavi, BSC1, Anahita Houshiarrad, MSC1, Maryam Chamari, MSC2 and Sepideh Asadzadeh, BSC1&lt;/p>
&lt;p>1 Department of Nutrition Research, National Nutrition and Food Technology Research Institute, and Faculty of Nutrition Science and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran&lt;/p></description></item><item><title>Genes such as CYP27B1, CYP24A1 and Vitamin D – JAMA</title><link>/posts/genes-such-as-cyp27b1-cyp24a1-and-vitamin-d-jama.html</link><pubDate>Tue, 13 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/genes-such-as-cyp27b1-cyp24a1-and-vitamin-d-jama.html</guid><description>&lt;h4 id="genetic-variants-and-associations-of-25-hydroxyvitamin-d-concentrations-with-major-clinical-outcomes">Genetic Variants and Associations of 25-Hydroxyvitamin D Concentrations With Major Clinical Outcomes&lt;/h4>
&lt;p>JAMA. 2012;308(18):1898-1905. doi:10.1001/jama.2012.17304.&lt;/p>
&lt;p>Gregory P. Levin, PhD; Cassianne Robinson-Cohen, PhD; Ian H. de Boer, MD, MS; Denise K. Houston, PhD; Kurt Lohman, MS; Yongmei Liu, PhD; Stephen B. Kritchevsky, PhD; Jane A. Cauley, DrPh; Toshiko Tanaka, PhD; Luigi Ferrucci, MD, PhD; Stefania Bandinelli, MD; Kushang V. Patel, PhD, MPH; Emil Hagström, MD, PhD; Karl Michaëlsson, MD, PhD; Håkan Melhus, MD, PhD; Thomas Wang, MD; Myles Wolf, MD, MMSc; Bruce M. Psaty, MD, PhD; David Siscovick, MD, MPH; Bryan Kestenbaum, MD, MS&lt;/p></description></item><item><title>600 mg of Calcium and a gene increases probability of Prostate Cancer by 50 pcnt</title><link>/posts/600-mg-of-calcium-and-a-gene-increases-probability-of-prostate-cancer-by-50-pcnt.html</link><pubDate>Tue, 06 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/600-mg-of-calcium-and-a-gene-increases-probability-of-prostate-cancer-by-50-pcnt.html</guid><description>&lt;h3 id="protective-effects-of-low-calcium-intake-and-low-calcium-absorption-vitamin-d-receptor-genotype-in-the-california-collaborative-prostate-cancer-study">Protective effects of low calcium intake and low calcium absorption vitamin D receptor genotype in the California Collaborative Prostate Cancer Study&lt;/h3>
&lt;p>Calcium Epidemiology Biomarkers and Prevention, November 5, 2012&lt;/p>
&lt;p>Glovioell W Rowland 1, Gary G. Schwartz 2, Esther M. John 3, and Sue Ann Ingles 4,ingles@usc.edu&lt;/p>
&lt;p>1 Preventive Medicine, University of Southern California&lt;/p>
&lt;p>2 Cancer Biology, Urology, and Epidemiology and Prevention, Wake Forest Baptist Medical Center&lt;/p>
&lt;p>3 Epidemiology, Cancer Prevention Institute of California&lt;/p></description></item><item><title>Vitamin D levels are strongly associated with genes: overview of twin studies</title><link>/posts/vitamin-d-levels-are-strongly-associated-with-genes-overview-of-twin-studies.html</link><pubDate>Mon, 05 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-levels-are-strongly-associated-with-genes-overview-of-twin-studies.html</guid><description/></item><item><title>CYP24A1 gene, kidney disease, and vitamin D</title><link>/posts/cyp24a1-gene-kidney-disease-and-vitamin-d.html</link><pubDate>Fri, 02 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/cyp24a1-gene-kidney-disease-and-vitamin-d.html</guid><description>&lt;h1 id="cyp24a1-and-kidney-disease">CYP24A1 and kidney disease&lt;/h1>
&lt;p>Curr Opin Nephrol Hypertens. 2011 May 22.&lt;/p>
&lt;p>Petkovich M, Jones G.&lt;/p>
&lt;p>aDivision of Cancer Biology and Genetics, Cancer Research Institute, Queen&amp;rsquo;s University, Kingston, Canada bDepartment of Research and Development, Cytochroma Inc., Markham, Canada cDepartments of Biochemistry and Medicine, Queen&amp;rsquo;s University, Kingston, Ontario, Canada.&lt;/p>
&lt;p>PURPOSE OF REVIEW:&lt;/p>
&lt;p>Patients with chronic renal disease have elevated serum phosphate levels, elevated fibroblast-like growth factor 23 (FGF-23), and declining vitamin D status. These changes are related and may be responsible for elevated 25-hydroxyvitamin D-24-hydroxylase (CYP24A1) and dysfunctional vitamin D metabolism. This review focuses on the biochemistry and pathophysiology of CYP24A1 and the utility of blocking this enzyme with CYP24A1 inhibitors in chronic kidney disease (CKD) patients.&lt;/p></description></item><item><title>CYP24A1 gene in cancer cells may actually remove vitamin D from the blood</title><link>/posts/cyp24a1-gene-in-cancer-cells-may-actually-remove-vitamin-d-from-the-blood.html</link><pubDate>Sat, 13 Oct 2012 00:00:00 +0000</pubDate><guid>/posts/cyp24a1-gene-in-cancer-cells-may-actually-remove-vitamin-d-from-the-blood.html</guid><description>&lt;h4 id="24-hydroxylase-in-cancer-impact-on-vitamin-d-based-anticancer-therapeutics">24-Hydroxylase in Cancer: Impact on Vitamin D-based Anticancer Therapeutics.&lt;/h4>
&lt;p>J Steroid Biochem Mol Biol. 2012 Oct 8. pii: S0960-0760(12)00200-2. &lt;a href="https://doi.org/10.1016/j.jsbmb.2012.09.031">doi: 10.1016/j.jsbmb.2012.09.031&lt;/a>&lt;/p>
&lt;p>Luo W, Hershberger PA, Trump DL, Johnson CS.&lt;/p>
&lt;p>Department of Pharmacology and Therapeutics.&lt;/p>
&lt;p>The active vitamin D hormone 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) plays a major role in regulating calcium homeostasis and bone mineralization. 1,25(OH)(2)D(3) also modulates cellular proliferation and differentiation in a variety of cell types. 24-hydroxylase, encoded by the CYP24A1 gene, is the key enzyme which converts 1,25(OH)(2)D(3) to less active calcitroic acid.&lt;/p></description></item><item><title>Vitamin D Shows Promise in Curing Baldness</title><link>/posts/vitamin-d-shows-promise-in-curing-baldness.html</link><pubDate>Sat, 28 Jul 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-shows-promise-in-curing-baldness.html</guid><description>&lt;h2 id="125-dihydroxyvitamin-d3-modulates-the-hair-inductive-capacity-of-dermal-papilla-cells-therapeutic-potential-for-hair-regeneration">1?,25-Dihydroxyvitamin D3 Modulates the Hair-Inductive Capacity of Dermal Papilla Cells: Therapeutic Potential for Hair Regeneration&lt;/h2>
&lt;p>Noriyuki Aoia, Keita Inouea, Toshihiro Chikanishib,c, Ryoji Fujikic, Hanako Yamamotod, Harunosuke Katoa, Hitomi Etoa, Kentaro Doia, Satoshi Itamie, Shigeaki Katob,c and Kotaro Yoshimuraa&lt;/p>
&lt;p>a Department of Plastic Surgery and&lt;/p>
&lt;p>d Department of Biochemistry and Molecular Biology, University of Tokyo School of Medicine, Tokyo, Japan;&lt;/p>
&lt;p>b ERATO, Japan Science and Technology Agency, Saitama, Japan;&lt;/p>
&lt;p>c Institute of Molecular and Cellular Biosciences, University of Tokyo, Tokyo, Japan;&lt;/p></description></item></channel></rss>